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1. Introduction {#sec1}
===============

Dengue, a viral disease caused by one of the four closely-related *Flavivirus* (DENV 1--4), is endemic in many tropical and subtropical regions of the world (with over 2.5 billion people at risk of acquiring dengue infection) ([@bib56]). Annually, the disease account for approximately 50 million cases and $20,000$ fatalities ([@bib55]; [@bib56]). Dengue and dengue haemorrhagic fever are on the rise in the Americas ([@bib34]; [@bib59]). In Latin America, about $78\text{\%}$ of the population (around 81 million people) live in urban areas, and the incidence of the rise has been on the increase in the past decade ([@bib32]; [@bib58]). In Puerto Rico, for example, almost 10,000 dengue fever cases are reported annually (dengue outbreaks are recorded in almost all Caribbean countries and Mexico ([@bib34]; [@bib59])). Dengue has also been periodically endemic in Texas over the past 20 years ([@bib34]; [@bib59]). The disease, which is transmitted to humans by female *Aedes aegypti* mosquito (following taking a blood meal, needed for eggs laying), threatens other non-endemic countries in Europe. For instance, the first local transmission of the disease in France and Croatia was recorded in 2010 ([@bib53]; [@bib62]) (outbreaks were also recorded in Madeira islands of Portugal in 2012, imported cases (mainly from Portugal) were also detected in three other European countries ([@bib62]; [@bib56])). Furthermore, in 2013, dengue outbreaks were recorded in Miami, USA and Yunnan province of China ([@bib24]; [@bib80]). Dengue causes life-threatening complications (such as Dengue Haemorrhagic fever and Dengue Shock syndrome ([@bib36])), often triggered by immune responses to secondary infections ([@bib76]).

The incidence of dengue has significantly increased globally over the last few years ([@bib24]; [@bib62]; [@bib56]). This is due to a number of factors ([@bib32]) (notably the geographic expansion, enhanced transmission intensity in endemic areas, variability in local weather and habitat conditions). Furthermore, vertical (transovarial) transmission, which has been observed in dengue transmission dynamics ([@bib21]; [@bib57]), is believed to retain dengue viral disease in nature during inter-epidemic periods of dengue ([@bib7]).

Changes in local temperature is known to significantly affect the dynamics of vector-borne diseases, including dengue ([@bib32]; [@bib78]). In particular, temperature variability affects the maturation, survival, biting rate and abundance of dengue-competent mosquitoes ([@bib32]). As the global temperature is increasing due to greenhouse-gas effects (daily average temperature in southern borders of USA have increased by ${0.4}^{\circ}$C over the past 30 years ([@bib41]); and it is estimated that global temperature will rise by $1.0 - {3.5}^{\circ}$C over the next 100 years ([@bib32]; [@bib78])), it is imperative to carry out detailed modeling studies to analyse the potential impact of such increases on the dynamics of vector-borne diseases (it should be mentioned that health risks due to these climate changes differ between countries, depending on the level of infrastructure and economic development ([@bib41])).

Vertical transmission (i.e., disease transmission from an infected mother to a child) is also another factor affecting the dynamics of many pathogens and diseases including dengue ([@bib3]; [@bib7]; [@bib22]; [@bib38]; [@bib42]). For instance, evidence for vertical transmission has been established in the dynamics of vector-borne diseases such as, *La Crosse virus* ([@bib49]), *St Louis Encephalitis* virus (([@bib52])), *West Nile* virus ([@bib11]) and *Yellow fever* ([@bib23]). Vertical transmission of dengue virus has been demonstrated in the lab in *Aedes aegypti*, *Aedes albopictus* and *Aedes scutellaris* mosquitoes ([@bib30]; [@bib37]; [@bib50]; [@bib63]; [@bib66]) (including in the wild ([@bib7]; [@bib38]; [@bib42])). It should also be mentioned that local temperature affects vertical transmission in the vector population. In subtropical regions, for example, dengue disease shows a resurgent pattern with yearly epidemics (which starts typically in the months with heavy rains and heat, peaking some 3 or 4 months after the beginning of the rainy season) ([@bib51]). In the dry months, the number of dengue cases typically drops essentially to zero (because the disease (vector) has virtually disappeared during this period) ([@bib51]). Dengue continues to re-emerge for many years in some regions ([@bib22]; [@bib32]). This (re-emergence) is attributed to many factors, such as the survival of long-lived infected adult female mosquitoes, infected eggs (laid by infected adult female mosquitoes, vertically) that remain infected during the dry season (and their hatching during the beginning of the raining season) ([@bib22]; [@bib32]; [@bib51]).

Although numerous climate variables (such as temperature, precipitation and humidity ([@bib17]; [@bib32]; [@bib41]; [@bib43])) affect the transmission dynamics of vector-borne diseases, the current study focuses on the singular effects of temperature. Consequently, the purpose of the current study is to use mathematical modeling approaches to gain insight into the role of temperature variability, and vertical transmission in the vector population, on the transmission dynamics of dengue disease in the community. A new deterministic model, which includes the dynamics of both the immature (i.e., modeling the eggs-larvae-pupae lifecycle stages) and adult female *Aedes aegypti* mosquitoes, as well as the effect of vector vertical transmission and temperature variability, will be designed. The paper is organized as follows. The model is designed in Section [2](#sec2){ref-type="sec"}. The case of the model where temperature is fixed (i.e., the *autonomous* equivalent of the *non-autonomous* model) is rigorously analysed (for the existence and asymptotic stability of some of its equilibria, as well as to characterize bifurcation types) in Section [3](#sec3){ref-type="sec"}. Uncertainty and sensitivity analysis of the parameters of this version of the model, as well as numerical simulations of the effect of temperature variability, are also carried out. The (full) non-autonomous model, which accounts for daily fluctuations in local temperature, is rigorously analysed in Section [4](#sec4){ref-type="sec"}.

2. Model formulation {#sec2}
====================

This study is motivated by dengue transmission dynamics in Chiang Mai province of Thailand ([@bib19]; [@bib61]; [@bib70]). Although there are four dengue serotypes (DENV 1--4), serological data from this province (for 2004 to 2010) shows that one of the four serotypes typically dominates the others each year ([@bib61]) (for example, in the year 2004, the percentage prevalence of DENV-1, DENV-2, DENV-3 and DENV-4 were $56.4\text{\%}$, $28.2\text{\%}$, $5.1\text{\%}$ and $10.3\text{\%}$, respectively ([@bib61])). Consequently, this study will consider only one dengue serotype in the community (this simplifying assumption allows for the tractability of the mathematical analysis to be carried out; a number of models for dengue transmission dynamics also use a single dengue serotype, such as those in ([@bib3]; [@bib22]; [@bib28]; [@bib31]; [@bib33]; [@bib36])).

The model to be designed is based, first of all, on splitting the total immature mosquito population at time *t* (denoted by $N_{VI}\left( t \right)$) into compartments of susceptible eggs ($S_{E}\left( t \right)$), infected eggs ($I_{E}\left( t \right)$), susceptible larvae ($S_{L}\left( t \right)$), infected larvae ($I_{L}\left( t \right)$), susceptible pupae ($S_{P}\left( t \right)$) and infected pupae ($I_{P}\left( t \right)$), so that$$N_{VI}\left( t \right) = S_{E}\left( t \right) + I_{E}\left( t \right) + S_{L}\left( t \right) + I_{L}\left( t \right) + S_{P}\left( t \right) + I_{P}\left( t \right).$$

Furthermore, the total adult female mosquito population at time *t* (denoted by $N_{VA}\left( t \right)$) is split into the sub-populations of susceptible adult female mosquitoes ($S_{M}\left( t \right)$) and infected adult female mosquitoes $\left( I_{M}\left( t \right) \right)$. Thus,$$N_{VA}\left( t \right) = S_{M}\left( t \right) + I_{M}\left( t \right).$$

Finally, the total human population at time *t* (denoted by $N_{H}\left( t \right)$) is sub-divided into susceptible ($S_{H}\left( t \right)$), exposed ($E_{H}\left( t \right)$), symptomatic ($I_{H}\left( t \right)$) and recovered ($R_{H}\left( t \right)$) humans. Hence,$$N_{H}\left( t \right) = S_{H}\left( t \right) + E_{H}\left( t \right) + I_{H}\left( t \right) + R_{H}\left( t \right).$$

The model to be designed incorporates the effect of variability in ambient (air) temperature (denoted by $T\left( t \right)$) on the dynamics of the mosquito-borne disease in a community. It is assumed that $T\left( t \right)$ is non-negative, continuous and bounded periodic functions of *t* (it is also assumed, for mathematical convenience, that air temperature and the temperature near the surface of the water are approximately the same; so that we can use $T\left( t \right)$ to approximate the temperature near the surface of the water where the development process of the immature mosquitoes occurs ([@bib7])).

The weather-driven model for the transmission dynamics of a vector-borne disease (dengue), with vertical transmission in the vector, is given by the following deterministic system of non-linear differential equations (the state variables and parameters of the model are described in [Table 2](#tbl2){ref-type="table"}, their ranges and values are given in [Table 3](#tbl3){ref-type="table"}; a flow diagram of the model is depicted in [Fig. 2](#fig2){ref-type="fig"}):$$\begin{array}{l}
{\frac{dS_{E}\left( t \right)}{dt} = \phi_{V}\left( T \right)\left\lbrack 1 - \frac{N_{VA}\left( t \right)}{K_{V}\left( t \right)} \right\rbrack_{+}\left\lbrack S_{M}\left( t \right) + \left( {1 - r} \right)I_{M}\left( t \right) \right\rbrack - \left\lbrack \sigma_{E}\left( T \right) + \mu_{E}\left( T \right) \right\rbrack S_{E}\left( t \right),} \\
{\frac{dI_{E}\left( t \right)}{dt} = r\phi_{V}\left( T \right)\left\lbrack 1 - \frac{N_{VA}\left( t \right)}{K_{V}\left( t \right)} \right\rbrack_{+}I_{M}\left( t \right) - \left\lbrack \sigma_{E}\left( T \right) + \mu_{E}\left( T \right) \right\rbrack I_{E}\left( t \right),} \\
{\frac{dS_{L}\left( t \right)}{dt} = \sigma_{E}\left( T \right)S_{E}\left( t \right) - \left\{ \left. \sigma_{L}\left( T \right) + \mu_{L}\left( T \right) + \delta_{L}\left( T \right)\left\lbrack S_{L}\left( t \right) + I_{L}\left( t \right) \right\rbrack \right\} \right.S_{L}\left( t \right)} \\
{\frac{dI_{L}\left( t \right)}{dt} = \sigma_{E}\left( T \right)I_{E}\left( t \right) - \left\{ \left. \sigma_{L}\left( T \right) + \mu_{L}\left( T \right) + \delta_{L}\left( T \right)\left\lbrack S_{L}\left( t \right) + I_{L}\left( t \right) \right\rbrack \right\} \right.I_{L}\left( t \right),} \\
{\frac{dS_{P}\left( t \right)}{dt} = \sigma_{L}\left( T \right)S_{L}\left( t \right) - \left\lbrack \sigma_{P}\left( T \right) + \mu_{P}\left( T \right) \right\rbrack S_{P}\left( t \right),} \\
{\frac{dI_{P}\left( t \right)}{dt} = \sigma_{L}\left( T \right)I_{L}\left( t \right) - \left\lbrack \sigma_{P}\left( T \right) + \mu_{P}\left( T \right) \right\rbrack I_{P}\left( t \right),} \\
{\frac{dS_{M}\left( t \right)}{dt} = f_{V}\sigma_{P}\left( T \right)S_{P}\left( t \right) - \left\lbrack \lambda_{HV}\left( {T,N_{H}\left( t \right),N_{VA}\left( t \right)} \right) + \mu_{V}\left( T \right) \right\rbrack S_{M}\left( t \right),} \\
{\frac{dI_{M}\left( t \right)}{dt} = f_{V}\sigma_{P}\left( T \right)I_{P}\left( t \right) + \lambda_{HV}\left( {T,N_{H}\left( t \right),N_{VA}\left( t \right)} \right)S_{M}\left( t \right) - \mu_{V}\left( T \right)I_{M}\left( t \right),} \\
{\frac{dS_{H}\left( t \right)}{dt} = \text{Π}_{H} - \left\lbrack \lambda_{VH}\left( {T,N_{H}\left( t \right),N_{VA}\left( t \right)} \right) + \mu_{H} \right\rbrack S_{H}\left( t \right),} \\
{\frac{dE_{H}\left( t \right)}{dt} = \lambda_{VH}\left( {T,N_{H}\left( t \right),N_{VA}\left( t \right)} \right)S_{H}\left( t \right) - \left( {\sigma_{H} + \mu_{H}} \right)E_{H}\left( t \right),} \\
{\frac{dI_{H}\left( t \right)}{dt} = \sigma_{H}E_{H}\left( t \right) - \left( {\gamma_{H} + \mu_{H}} \right)I_{H}\left( t \right),} \\
{\frac{dR_{H}\left( t \right)}{dt} = \gamma_{H}I_{H}\left( t \right) - \mu_{H}R_{H}\left( t \right),} \\
\end{array}$$where,$$\lambda_{HV}\left( {T,N_{H}\left( t \right),N_{VA}\left( t \right)} \right) = \frac{a_{V}\left( T \right)\beta_{V}\left( T \right)I_{H}\left( t \right)}{N_{H}\left( t \right)},\lambda_{VH}\left( {T,N_{H}\left( t \right),N_{VA}\left( t \right)} \right) = \frac{a_{V}\left( T \right)\beta_{H}\left( T \right)I_{M}\left( t \right)}{N_{H}\left( t \right)}.$$Table 1Proportion of infected eggs (*r*) for various dengue subtypes.Table 1SpeciesDengue subtypeProportion of infected eggs (*r*) *per*$1,000$Reference*Ae. aegypti*DENV-1-4\[0.61--15\]([@bib33]; [@bib63])*Ae. albopictus*DENV-1\[1.7--14\]([@bib33])DENV-2\[0.91--2.5\]([@bib33])DENV-3\[0.23--0.78\]([@bib33])DENV-4\[0.22--5.2\]([@bib33])Table 2Description of variables and parameters of the model [(2.1)](#fd2_1){ref-type="disp-formula"}.Table 2SymbolDescription**Variables**$S_{E}$Number of susceptible eggs$I_{E}$Number of infected eggs$S_{L}$Number of susceptible larvae$I_{L}$Number of infected larvae$S_{P}$Number of susceptible pupae$I_{P}$Number of infected pupae$S_{M}$Population of susceptible adult female mosquitoes$I_{M}$Population of infected adult female mosquitoes$S_{H}$Population of susceptible humans$E_{H}$Population of latently-exposed humans$I_{H}$Population of symptomatically-infected humans$R_{H}$Population of recovered humans$N_{VI}$Total population of immature mosquitoes$N_{VA}$Total population of adult female mosquitoes$N_{H}$Total population of humans**Parameters**$\sigma_{E}\left( T \right)$Hatching rate of eggs into larvae$\mu_{E}\left( T \right)$Natural mortality rate of eggs$\sigma_{L}\left( t \right)$Maturation rate of larvae to pupae$\mu_{L}\left( T \right)$Natural mortality rate of larvae$\delta_{L}\left( T \right)$Density-dependent mortality rate of larvae$\sigma_{P}\left( T \right)$Maturation rate of pupae to adult mosquito$\mu_{P}\left( T \right)$Natural mortality rate of pupae$\lambda_{HV}\left( {T,N_{H},N_{VA}} \right)$Transmission rate from infected humans to susceptible mosquitoes$\lambda_{VH}\left( {T,N_{H},N_{VA}} \right)$Transmission rate from infected mosquitoes to susceptible humans$a_{V}\left( T \right)$*Per capita* contact (biting) rate of adult female mosquitoes on humans$\phi_{V}\left( T \right)$*Per capita* egg oviposition rate$\mu_{V}\left( T \right)$Natural mortality rate of adult mosquitoes$K_{V}\left( t \right)$Carrying capacity of breeding habitats for adult female mosquitoes to lay eggss$f_{V}$Proportion of new adult mosquitoes that are females$\mu_{H}$Natural mortality rate of humans$\sigma_{H}$Rate of development of disease symptoms in humans$\gamma_{H}$Recovery rate for humans$\text{Π}_{H}$Recruitment rate (by birth and immigration) into the community$\beta_{V}$Probability of infection of a susceptible mosquito *per* bite on an infected human$\beta_{H}$Probability of infection of a susceptible human *per* bite by an infected mosquito*r*Proportion of infected eggs laid by infected adult female mosquitoes(due to vertical transmission)Table 3Values and ranges of the parameters of autonomous version of the model [(2.1)](#fd2_1){ref-type="disp-formula"}.Table 3ParameterRangeBaseline valueReference$\sigma_{E}$(0.1,0.5)/day0.4/day([@bib20]; [@bib29])$\mu_{E}$(0.07,0.3)/day0.2([@bib20]; [@bib29])$\sigma_{L}$(0.08,0.35)/day0.14/day([@bib20]; [@bib29])$\mu_{L}$(0.07,0.3)/day0.18/day([@bib20]; [@bib29])$\sigma_{P}$(0.1,0.5)/day0.3/day([@bib20]; [@bib29])$\mu_{P}$(0.07,0.25)/day0.17/day([@bib20]; [@bib29])$a_{V}$(0,1)/day0.12/day([@bib6])$\mu_{V}$(0.047,0.071)/day0.05/day([@bib4]; [@bib18]; [@bib45])$\mu_{H}$(0.00003,0.000042)/day0.00005/day([@bib73])$\sigma_{H}$(0,1)/day0.15/day([@bib31])$\gamma_{H}$(0,1)/day0.1428/day([@bib31])$\text{Π}_{H}$(60,300)/day66/day([@bib19])$\beta_{V}$(0.3,0.75)0.5([@bib29]; [@bib31])$\beta_{H}$(0.1,0.75)0.4([@bib29]; [@bib31])*r*(0,0.3)0.007([@bib13]; [@bib30]; [@bib66])$f_{V}$(0.4,0.6)0.55([@bib46])$K_{V}$$\left( 10^{4},10^{6} \right)$40,000([@bib4]; [@bib45])$\phi_{V}$(1500)1.84([@bib4]; [@bib18]; [@bib45])Fig. 1Schematic description of the lifecycle of the *Aedes aegypti* mosquito ([@bib27]).Fig. 1Fig. 2Flow diagram of the model [(2.1)](#fd2_1){ref-type="disp-formula"}. Notation: Red arrow indicates infection route.Fig. 2

In the model [(2.1)](#fd2_1){ref-type="disp-formula"}, eggs are laid by adult female *Aedes aegypti* mosquitoes at a logistic growth rate $\phi_{V}\left( T \right)\left\lbrack {1 - \frac{N_{VA}\left\lbrack t \right\rbrack}{K_{V}\left\lbrack t \right\rbrack}} \right\rbrack_{+}$, where $\phi_{V}\left( T \right)$ is the temperature-dependent egg oviposition rate, $K_{V}\left( t \right)$ is the carrying capacity of the breeding habitats for adult female mosquitoes to lay eggs. The notation $\left( m \right)_{+}$, where $m_{+} = \text{max}\left\{ {0,m} \right\}$ with $m > 0$, is used to ensure that the term $\left( {1 - \frac{N_{VA}\left( t \right)}{K_{V}\left( t \right)}} \right) > 0$ for all *t*. The parameter *r* (with $0 \leq r < 1$) represents the proportion of mosquito offsprings that are born infected (due to vertical transmission). [Table 1](#tbl1){ref-type="table"} shows the average proportion of eggs laid that are infected, for various subtypes of dengue fever, based on laboratory experiments ([@bib33]; [@bib63]).

Eggs hatch into larvae at a temperature-dependent rate $\sigma_{E}\left( T \right)$, larvae mature into pupae at a temperature-dependent rate $\sigma_{L}\left( T \right)$, and pupae become adult female mosquitoes at a temperature-dependent rate $f_{V}\sigma_{P}\left( T \right)$ (where $0 < f_{V} < 1$ is the proportion of new adult mosquitoes that are females). Eggs, larvae and pupae suffer natural mortality loss at temperature-dependent rates $\mu_{E}\left( T \right),\mu_{L}\left( T \right)$ and $\mu_{P}\left( t \right)$, respectively. Larvae suffer additional density-dependent mortality at a temperature-dependent rate $\delta_{L}\left( T \right)\left( {S_{L}\left( t \right) + I_{L}\left( t \right)} \right)$ ([@bib47]). A schematic diagram of the mosquito lifecycle is depicted in [Fig. 1](#fig1){ref-type="fig"}.

Susceptible adult female mosquitoes acquire dengue infection, following effective contact with an infected human (after taking a blood meal), at a rate $\lambda_{HV}$ (given in [(2.2)](#fd2_2){ref-type="disp-formula"}), where $a_{V}\left( T \right)$ is the temperature-dependent effective contact (biting) rate of adult female mosquitoes on humans (regardless of infectious status of the vector or the host), $\beta_{V}\left( T \right)$ is the temperature-dependent probability that a bite from a susceptible adult female mosquito to an infected human results in an infection. Adult mosquitoes suffer natural death at a temperature-dependent rate ($\mu_{V}\left( T \right)$). The parameter $\text{Π}_{H}$ represents the *per capita* recruitment rate of humans into the community (by birth or immigration). Susceptible humans acquire dengue infection, following effective contact with an infected adult female mosquito, at a rate $\lambda_{VH}$ (given in [(2.2)](#fd2_2){ref-type="disp-formula"}), where $a_{V}\left( T \right)$ is as defined above, and $\beta_{H}\left( T \right)$ is the temperature-dependent probability of infection from an infected mosquito to a susceptible human *per* bite. Exposed humans develop clinical symptoms of the disease at a rate $\sigma_{H}$. Infectious humans recover at a rate $\gamma_{H}$ (it is assumed that recovery induces permanent immunity against reinfection). Natural death occurs in all human compartments at a rate $\mu_{H}$. Since dengue-induced mortality in humans is generally negligible ([@bib4]; [@bib18]; [@bib31]; [@bib45]; [@bib64]) (for instance, there were only 126 dengue-induced fatalities in Thailand in 2017 ([@bib64])), no human disease-induced mortality is assumed in the model. Furthermore, no disease-induced mortality is assumed in the adult mosquito population.

The model [(2.1)](#fd2_1){ref-type="disp-formula"} is an extension of numerous dengue transmission models that include vertical transmission in the vector population (such as those in ([@bib3]; [@bib22]; [@bib28]; [@bib31]; [@bib33]; [@bib36])) by (*inter alia*):(i)adding the dynamics of immature mosquitoes (this was not included in ([@bib28]; [@bib31]; [@bib36]));(ii)incorporating the effect of temperature variability (this was not considered in ([@bib3]; [@bib28]; [@bib31]));(iii)including the effects of temperature on vertical transmission in the vector population and on the dynamics of dengue disease (this was not considered in ([@bib22]; [@bib28]; [@bib36])).

2.1. Functional forms of temperature-dependent parameters for adult mosquitoes {#sec2.1}
------------------------------------------------------------------------------

The functional forms of the temperature-dependent parameters of the model related to adult mosquitoes *Aedes aegypti* (namely, $a_{V}\left( T \right)$, $\beta_{H}\left( T \right)$, $\beta_{V}\left( T \right)$, $\phi_{V}\left( T \right)$ and $\mu_{V}\left( T \right)$) are defined as follows (for ${12.4}^{\circ}$C $< T\left( t \right) < 32^{\circ}$C):1.The biting rate of adult female mosquitoes on the human host ($a_{V}$) is given by (see ([@bib65]), [Fig. 5](#fig5){ref-type="fig"}):$$a_{V}\left( T \right) = 0.0943 + 0.0043T.$$Fig. 3Profile of the functional forms of the temperature-dependent parameters of the model [(2.1)](#fd2_1){ref-type="disp-formula"} related to the adult *Aedes aegypti* mosquito. (a) Probability of infection from an infected mosquito to a susceptible human *per* bite ($\beta_{H}\left( T \right)$). (b) The biting rate of adult female mosquitoes ($a_{V}\left( T \right)$). (c) Probability of infection from an infected human to a susceptible mosquito *per* bite ($\beta_{V}\left( T \right)$). (d) Egg oviposition rate ($\phi_{V}\left( T \right)$). (e) Mortality rate of adult female mosquito ($\mu_{V}\left( T \right)$).Fig. 3Fig. 4Data fittings of the autonomous version of the model [(2.1)](#fd2_1){ref-type="disp-formula"}. (a) Plot of the average monthly temperature (in °C) for Chiang Mai ([Table 5](#tbl5){ref-type="table"}) superimposed with the monthly dengue incidence data ([Table 6](#tbl6){ref-type="table"}). (b) Data fitting of the model [(2.1)](#fd2_1){ref-type="disp-formula"} using the average monthly incidence data in [Table 6](#tbl6){ref-type="table"} (and the fitted monthly biting rates in [Table 7](#tbl7){ref-type="table"}). (c) Fitted biting rate ($a_{V}$) used to fit the model with the data. Plots are generated using the baseline parameter values in [Table 3](#tbl3){ref-type="table"}.Fig. 4Fig. 5Profile of the reproduction number (${\mathbb{R}}_{0V}$) as a function of mean monthly temperature for Chiang Mai Thailand. Parameters values used as given by the baseline values in [Table 3](#tbl3){ref-type="table"}.Fig. 52.The probability of infection from an infected mosquito to a susceptible human ($\beta_{H}$) *per* bite is given by (see ([@bib44]), [Supporting Information](#appsec4){ref-type="sec"}):$$\beta_{H}\left( T \right) = 0.001044T\left( {T - 12.286} \right)\sqrt{32.461 - T}.$$3.The probability of infection from an infected human to a susceptible mosquito *per* bite ($\beta_{V}$) is given by (see ([@bib44]), [Supporting Information](#appsec4){ref-type="sec"}):$$\beta_{V}\left( T \right) = - 0.9037 + 0.0729T.$$4.The oviposition rate ($\phi_{V}$) is given by (([@bib44])):$$\phi_{V}\left( T \right) = - 15.837 + 1.2897T - 0.0163T^{2}.$$5.The mortality rate $\mu_{V}$ of the *Aedes aegypti* mosquito is given by ([@bib79]):$$\mu_{V}\left( T \right) = 0.8692 - 0.159T + 0.01116T^{2} - 3.408 \times 10^{- 4}T^{3} + 3.809 \times 10^{- 6}T^{4}.$$

The aforementioned functional forms are depicted in [Fig. 3](#fig3){ref-type="fig"}. Furthermore, typically, a sinusoidal function of the following form is used to account for hourly fluctuations in local ambient temperature ([@bib54]):$$T\left( t \right) = T_{0} - \frac{\text{Δ}_{T}}{2}\text{sin}\left\lbrack {\frac{2\pi}{24}\left( {t_{h} + 14} \right)} \right\rbrack,$$where $T_{0}$ is the mean daily air temperature, $\text{Δ}_{T}$ captures variation about the mean (i.e., $\text{Δ}_{T}$ is the diurnal temperature range), and $t_{h}$ denotes for time in hour for any given day.

If a formulation such as [(2.8)](#fd2_8){ref-type="disp-formula"} is used for the temperature-dependent functional forms, then the parameters defined in Equations [(2.5)](#fd2_5){ref-type="disp-formula"}, [(2.6)](#fd2_6){ref-type="disp-formula"}, [(2.7)](#fd2_7){ref-type="disp-formula"}, [(2.3)](#fd2_3){ref-type="disp-formula"}, [(2.4)](#fd2_4){ref-type="disp-formula"} are time-dependent. Hence, the model [(2.1)](#fd2_1){ref-type="disp-formula"} is *non-autonomous*. However, if fixed temperature values are used (e.g., using the mean daily or mean monthly temperature), then each of the parameters defined in Equations [(2.5)](#fd2_5){ref-type="disp-formula"}, [(2.6)](#fd2_6){ref-type="disp-formula"}, [(2.7)](#fd2_7){ref-type="disp-formula"}, [(2.3)](#fd2_3){ref-type="disp-formula"}, [(2.4)](#fd2_4){ref-type="disp-formula"} is constant. Hence, the model [(2.1)](#fd2_1){ref-type="disp-formula"} is *autonomous* in this case. In the absence of good data to realistically derive the functional forms for the other temperature-dependent parameters related to the immature *Aedes aegypti* mosquitoes (i.e., $\sigma_{E}\left( T \right)$, $\mu_{E}\left( T \right)$, $\sigma_{L}\left( T \right)$, $\mu_{L}\left( T \right)$, $\sigma_{P}\left( T \right)$ and $\mu_{P}\left( T \right)$), numerical simulations of the model [(2.1)](#fd2_1){ref-type="disp-formula"} will be carried out using fixed (constant) values for these parameters (available in the literature).

2.2. Data fitting {#sec2.2}
-----------------

The model [(2.1)](#fd2_1){ref-type="disp-formula"} is, first of all, fitted using available epidemiological and weather data relevant (see [Table 3](#tbl3){ref-type="table"}, [Table 5](#tbl5){ref-type="table"}, [Table 6](#tbl6){ref-type="table"}) to dengue transmission dynamics in the Chiang Mai province of Thailand ([@bib14]; [@bib70]) (using least square regression). In particular, both the temperature data (provided by Thai Meteorological Department ([@bib70])) and incidence data (provided by Thailand Bureau of Epidemiology ([@bib14]); see also [Appendix A](#appsec1){ref-type="sec"}) are given for monthly periods between 2005 and 2016. The mean monthly temperature for Chiang Mai (given in [Table 5](#tbl5){ref-type="table"}) is plotted alongside the average monthly dengue incidence (given in [Table 6](#tbl6){ref-type="table"}) in [Fig. 4](#fig4){ref-type="fig"} (a). This figure shows that peak dengue incidence is attained for temperatures between $26^{\circ}$C and $28^{\circ}$C, which are recorded in the Chiang Mai province during the period between June and August annually.Table 5Mean monthly temperature (in °C) for Chiang Mai province of Thailand for the period 2005--2016 ([@bib70]).Table 5MonthJanFebMarAprMayJunJulAugSepOctNovDecHigh28.932.234.936.134.132.331.731.131.331.129.828.3Mean20.522.926.428.728.127.327.026.626.525.823.821.0Low13.714.918.221.823.423.723.623.423.021.819.015.0Table 6Average monthly dengue incidence data for Chiang Mai province of Thailand, for the period 2005--2016 ([@bib16]).Table 6MonthDengue cases *per*$100,000$January3.8February2.3March3.5April7.5May21.4June51.63July73.33August72.61September45.14October23.82November17.44December7.38Table 7Fitted values of monthly biting rates (obtained from fitting the model with data).Table 7MonthJanFebMarAprMayJunJulAugSepOctNovDecBiting rate ($a_{V}$)0.050.010.010.090.150.120.150.10.050.030.020.02

Furthermore, the model [(2.1)](#fd2_1){ref-type="disp-formula"} is fitted using the aforementioned mean monthly temperature and incidence data ([Table 5](#tbl5){ref-type="table"}, [Table 6](#tbl6){ref-type="table"}) using the baseline parameter values given in [Table 3](#tbl3){ref-type="table"}, where the temperature-dependent biting rate ($a_{V}\left( T \right)$) is chosen as a fitting parameter (and the remaining temperature-dependent parameters of the model are computed using their respective functional forms given in Section [2.1](#sec2.1){ref-type="sec"}). The result obtained, depicted in [Fig. 4](#fig4){ref-type="fig"} (b), shows a reasonably good fit. Plots of the fitted biting rates (using the data in [Table 3](#tbl3){ref-type="table"}) and the incidence data (given in [Table 6](#tbl6){ref-type="table"}) are depicted in [Fig. 4](#fig4){ref-type="fig"} (c), from which it follows that the dengue incidence positively correlates with increasing biting rate.

2.3. Basic qualitative properties {#sec2.3}
---------------------------------

Since the model [(2.1)](#fd2_1){ref-type="disp-formula"} monitors the temporal dynamics of mosquitoes (immature and mature) and humans, all parameters of the model are assumed to be non-negative. Define the region$$\mathcal{D} = \left\{ {\left\{ {S_{E},I_{E},S_{L},I_{L},S_{P},I_{P},S_{M},I_{M},S_{H},E_{H},I_{H},R_{H}} \right\} \in {\mathbb{R}}_{+}^{12}} \right\}.$$Theorem 2.1*If the initial values of the system* [(2.1)](#fd2_1){ref-type="disp-formula"} *lie in the region* $\mathcal{D}$*, then there exists a unique positive solution for* [(2.1)](#fd2_1){ref-type="disp-formula"}*, such that*$$\text{Γ} = \left\{ {\left( {S_{E},I_{E},S_{L},I_{L},S_{P},I_{P},S_{M},I_{M},S_{H},E_{H},I_{H},R_{H}} \right) \in \mathcal{D}:N_{V}\left( t \right) \leq m_{1},N_{H}\left( t \right) \leq m_{2},t \geq 0} \right\}$$is positively-bounded and invariant for the model [(2.1)](#fd2_1){ref-type="disp-formula"}, where $0 \leq m_{1},m_{2} < \infty$.

Proof. The right-hand side of the expressions in the model [(2.1)](#fd2_1){ref-type="disp-formula"} are continuous, with continuous partial derivatives in $\mathcal{D}$. Hence, the model has a unique solution that exists for all time *t* ([@bib60]). It remains to be shown that the region $\mathcal{D}$ is forward (positively)-invariant. Setting $S_{E}\left( t \right) = 0$ in the model [(2.1)](#fd2_1){ref-type="disp-formula"} shows that $\frac{dS_{E}}{dt} \geq 0$ for all $t \geq 0$. Similarly, it can be shown that $I_{E}\left( t \right) \geq 0$, $S_{L}\left( t \right) \geq 0$, $I_{L}\left( t \right) \geq 0$, $S_{P}\left( t \right) \geq 0$, $I_{P}\left( t \right) \geq 0$, $S_{M}\left( t \right) \geq 0$, $I_{M}\left( t \right) \geq 0$, $S_{H}\left( t \right) \geq 0$, $E_{H}\left( t \right) \geq 0$, $I_{H}\left( t \right) \geq 0$ and $R_{H}\left( t \right) \geq 0$ for all $t \geq 0$ (Theorem A4 of ([@bib72])).

For the invariance of $\text{Γ}$, it is convenient to let (for each initial data) $N_{V}\left( t \right) = N_{VI}\left( t \right) + N_{VA}\left( t \right)$. Adding the first eight equations of the model [(2.1)](#fd2_1){ref-type="disp-formula"} gives:$$\begin{matrix}
{{\frac{dN_{V}}{dt} = \phi_{V}N_{VA}\left\lbrack 1 - \frac{N_{VA}}{K_{V}\left( t \right)} \right\rbrack}_{+} - \mu_{E}\left( {S_{E} + I_{E}} \right) - \mu_{L}\left( {S_{L} + I_{L}} \right) - \mu_{P}\left( {S_{P} + I_{P}} \right)} \\
{- \mu_{V}\left( {S_{M} + I_{M}} \right) - \delta_{L}\left( {S_{L} + I_{L}} \right)^{2} + \sigma_{P}f_{V}\left( {S_{P} + I_{P}} \right) - \sigma_{P}\left( {S_{P} + I_{P}} \right)} \\
{\leq \phi_{V}K_{V}\left( t \right) - \mu_{min}N_{V},} \\
\end{matrix}$$where, $\mu_{min} = \text{min}\left\{ {\mu_{E},\mu_{L},\mu_{P},\mu_{V}} \right\}$. Since $N_{VA}\left( t \right) < K_{V}\left( t \right)$, for all $t \geq 0$ (and noting that $K_{V}\left( t \right)$ is bounded for all $t \geq 0$ ([@bib2])), then:$$N_{V}\left( t \right) \leq e^{- \mu_{min}t}\left\lbrack \int_{0}^{t}e^{\mu_{min}s}\phi_{V}K_{V}\left( s \right)ds + N_{V}\left( 0 \right) \right\rbrack = m_{1}.$$

Finally, adding the last four equations of the model [(2.1)](#fd2_1){ref-type="disp-formula"} gives;$$\frac{dN_{H}}{dt} = \text{Π}_{H} - \mu_{H}\left( {S_{H} + E_{H} + I_{H} + R_{H}} \right) \leq \text{Π}_{H} - \mu_{H}N_{H},$$so that,$$N_{H}\left( t \right) \leq e^{- \mu_{H}t}\left\lbrack \text{Π}_{H}\int_{0}^{t}e^{\mu_{H}s}ds + N_{H}\left( 0 \right) \right\rbrack = m_{2}.$$

Thus, $N_{V}\left( t \right)$ and $N_{H}\left( t \right)$ are positively-bounded for all $t \geq 0$. ∎

3. Analysis of autonomous version of the model {#sec3}
==============================================

The model [(2.1)](#fd2_1){ref-type="disp-formula"} will, first of all, be analysed for the case when fixed temperature values are used (i.e., the *autonomous* equivalent/version of the model [(2.1)](#fd2_1){ref-type="disp-formula"} will be considered first).

3.1. Disease-free equilibria {#sec3.1}
----------------------------

It is convenient to define the quantity$$r_{0} = \frac{\phi_{V}f_{V}\sigma_{E}\sigma_{L}\sigma_{P}}{\mu_{V}\left( {\sigma_{E} + \mu_{E}} \right)\left( {\sigma_{L} + \mu_{L}} \right)\left( {\sigma_{P} + \mu_{P}} \right)}.$$

The autonomous version of the model [(2.1)](#fd2_1){ref-type="disp-formula"} has two disease-free equilibria, described below:1.Trivial (mosquito-free) disease-free equilibrium (TDFE):$$\begin{matrix}
{\mathcal{T}_{0} = \left( {S_{E}^{\text{*}},I_{E}^{\text{*}},S_{L}^{\text{*}},I_{L}^{\text{*}},S_{P}^{\text{*}},I_{P}^{\text{*}},S_{M}^{\text{*}},I_{M}^{\text{*}},S_{H}^{\text{*}},E_{H}^{\text{*}},I_{H}^{\text{*}},R_{H}^{\text{*}}} \right)} \\
{= \left( {0,0,0,0,0,0,0,0,\frac{\text{Π}_{H}}{\mu_{H}},0,0,0} \right).} \\
\end{matrix}$$2.Non-trivial (mosquito-present) disease-free equilibrium (NDFE):$$\begin{matrix}
{\mathcal{T}_{1} = \left( {S_{E}^{\dagger},I_{E}^{\dagger},S_{L}^{\dagger},I_{L}^{\dagger},S_{P}^{\dagger},I_{P}^{\dagger},S_{M}^{\dagger},I_{M}^{\dagger},S_{H}^{\dagger},E_{H}^{\dagger},I_{H}^{\dagger},R_{H}^{\dagger}} \right)} \\
{= \left( {S_{E}^{\dagger},0,S_{L}^{\dagger},0,S_{P}^{\dagger},0,S_{M}^{\dagger},0,\frac{\text{Π}_{H}}{\mu_{H}},0,0,0} \right),} \\
\end{matrix}$$where,$$\begin{array}{l}
{S_{M}^{\dagger} = \frac{k_{1}}{k_{2} + \delta_{L}k_{3}^{2}}\left( {r_{0} - 1} \right),S_{E}^{\dagger} = \frac{\phi_{V}}{\sigma_{E} + \mu_{E}}\left( {1 - \frac{S_{M}^{\dagger}}{K_{V}}} \right)_{+}S_{M}^{\dagger},S_{P}^{\dagger} = \frac{\sigma_{L}S_{L}^{\dagger}}{\sigma_{P} + \mu_{P}},} \\
{S_{L}^{\dagger} = \frac{- \left( {\sigma_{L} + \mu_{L}} \right) + \sqrt{\left( {\sigma_{L} + \mu_{L}} \right)^{2} + 4\sigma_{E}\delta_{L}S_{E}^{\dagger}}}{2\delta_{L}},} \\
\end{array}$$with $k_{1} = \frac{\mu_{V}\left( {\sigma_{P} + \mu_{P}} \right)\left( {\sigma_{L} + \mu_{L}} \right)}{f_{V}\sigma_{P}\sigma_{L}},$ $k_{2} = \frac{\phi_{V}\sigma_{E}}{K_{V}\left( {\sigma_{E} + \mu_{E}} \right)}$, $k_{3} = \frac{\mu_{V}\left( {\sigma_{P} + \mu_{P}} \right)}{f_{V}\sigma_{L}\sigma_{P}}$ and $K_{V} > S_{M}^{\dagger}$ in $\mathcal{D}$. It follows from [(3.2)](#fd3_2){ref-type="disp-formula"} that $\mathcal{T}_{1}$ exists if and only if $r_{0} > 1$. The quantity $r_{0}$ represents the average number of new adult female mosquitoes generated by a single susceptible adult female mosquito that has successfully taken a blood meal. It is the product of the rate at which eggs are laid eggs by an adult female mosquito ($\phi_{V}$), the proportion of eggs survived to become larvae ($\frac{\sigma_{E}}{\sigma_{E} + \mu_{E}}$), proportion of larvae survived and matured into pupae ($\frac{\sigma_{L}}{\sigma_{L} + \sigma_{L}}$), proportion of pupae survived and become adult female mosquitoes ($\frac{\sigma_{P}f_{V}}{\sigma_{P} + \mu_{P}}$), and the average lifespan of a susceptible adult female mosquito ($\frac{1}{\mu_{V}}$).

### 3.1.1. Local asymptotic stability of TDFE ($\mathcal{T}_{0}$) {#sec3.1.1}

The TDFE $\left( \mathcal{T}_{0} \right)$, which always exists, corresponds to the case without mosquitoes. It can be shown, by linearizing the autonomous version of the model [(2.1)](#fd2_1){ref-type="disp-formula"} around $\mathcal{T}_{0}$, that the associated eigenvalues of the linearization have negative real part whenever$$r_{VH}^{v} = \text{max}\left\{ {r_{0},rr_{0}} \right\} < 1,$$where, $r_{0}$ is given in (3.1). Since we assumed $0 \leq r < 1$, it follows that $r_{VH}^{v} = r_{0}$ in this case. The following result can be established using standard linearization of the autonomous version of the model [(2.1)](#fd2_1){ref-type="disp-formula"} around the TDFE ($\mathcal{T}_{0}$).Theorem 3.1*The TDFE point (*$\mathcal{T}_{0}$*) is locally-asymptotically stable (LAS) whenever* $r_{VH}^{v} < 1$*, and unstable if* $r_{VH}^{v} > 1$.

It is worth noting that, since the quantity $r_{0}$ is the average number of new susceptible adult female mosquitoes generated by a single susceptible adult female mosquito that has successfully taken a blood meal, the quantity $rr_{0}$ measures the average number of new infected adult female mosquitoes generated by a single infected adult female mosquito that has successfully taken a blood meal. It is worth noting, from the expression (3.3), the threshold quantity $r_{HV}^{v}$ increases with increasing values of *r*. That is, as expected, increasing the vertical transmission rate ($0 \leq r < 1$) increase the disease burden (by increasing in $r_{VH}^{v}$).

### 3.1.2. Local asymptotic stability of NDFE $\left( \mathcal{T}_{1} \right)$ {#sec3.1.2}

The local asymptotic stability of $\mathcal{T}_{1}$ can be established using the next generation operator method ([@bib25]; [@bib26]). The non-negative matrix $\mathcal{F}$ of new infection terms and the matrix $\mathcal{V}$ of the transition terms associated with the autonomous case of the model [(2.1)](#fd2_1){ref-type="disp-formula"} are, respectively, given by:$$\mathcal{F} = \begin{bmatrix}
0 & 0 & 0 & {\phi_{V}r\left( {1 - \frac{S_{M}^{\dagger}}{K_{V}}} \right)_{+}} & 0 & 0 \\
0 & 0 & 0 & 0 & 0 & 0 \\
0 & 0 & 0 & 0 & 0 & 0 \\
0 & 0 & 0 & 0 & 0 & \frac{\beta_{V}a_{V}S_{M}^{\dagger}}{N_{H}^{\dagger}} \\
0 & 0 & 0 & {\beta_{H}a_{V}} & 0 & 0 \\
0 & 0 & 0 & 0 & 0 & 0 \\
\end{bmatrix},\mathcal{V} = \begin{bmatrix}
g_{1} & 0 & 0 & 0 & 0 & 0 & \\
{- \sigma_{E}} & g_{2} & 0 & 0 & 0 & 0 & \\
0 & {- \sigma_{L}} & g_{3} & 0 & 0 & 0 & \\
0 & 0 & {- f_{V}\sigma_{P}} & g_{4} & 0 & 0 & \\
0 & 0 & 0 & 0 & g_{5} & 0 & \\
0 & 0 & 0 & 0 & {- \sigma_{H}} & g_{6} & \\
\end{bmatrix},$$where, $g_{1} = \sigma_{E} + \mu_{E}$, $g_{2} = \sigma_{L} + \mu_{L}$, $g_{3} = \sigma_{P} + \mu_{P}$, $g_{4} = \mu_{V}$, $g_{5} = \sigma_{H} + \mu_{H}$, and $g_{6} = \gamma_{H} + \mu_{H}$. It follows, from ([@bib26]), that the basic reproduction number (${\mathbb{R}}_{0V}$) of autonomous case of the model [(2.1)](#fd2_1){ref-type="disp-formula"} is given by (where ρ is the spectral radius):$${\mathbb{R}}_{0V} = \rho\left( {\mathcal{F}\mathcal{V}^{- 1}} \right) = \frac{1}{2}\left\lbrack {\mathbb{R}}_{V}^{v} + \sqrt{\left( {\mathbb{R}}_{V}^{v} \right)^{2} + 4{\mathbb{R}}_{0}} \right\rbrack,$$with, ${\mathbb{R}}_{V}^{v} = rr_{0}\left( {1 - \frac{S_{M}^{\dagger}}{K_{V}}} \right)_{+}$ and ${\mathbb{R}}_{0} = \frac{a_{V}^{2}\beta_{V}\beta_{H}S_{M}^{\dagger}}{\mu_{V}\left( {\sigma_{H} + \mu_{H}} \right)\left( {\gamma_{H} + \mu_{H}} \right)N_{H}^{\dagger}}$. It is worth noting from [(3.5)](#fd3_5){ref-type="disp-formula"} that, in the absence of vertical transmission, the reproduction threshold (${\mathbb{R}}_{0V}$) reduces to$${\mathbb{R}}_{0V}|_{r = 0} = \sqrt{{\mathbb{R}}_{0}}\ .$$

The result below follows from Theorem 2 of ([@bib26]).Theorem 3.2*The NDFE (*$\mathcal{T}_{1}$*) is LAS whenever* ${\mathbb{R}}_{0V} < 1$*, and unstable if* ${\mathbb{R}}_{0V} > 1$.

The epidemiological implication of [Theorem 3.2](#enun_Theorem_3_2){ref-type="statement"} is that a small influx of infected individuals or vectors into the population will not generate a large outbreak in the community if ${\mathbb{R}}_{0V} < 1$. Hence, the disease may be effectively-controlled if ${\mathbb{R}}_{0V}$ can be brought to (and maintained at) values less than unity. A plot of ${\mathbb{R}}_{0V}$, as a function of fixed mean monthly temperature (for $T\left( t \right) \in \left\lbrack 14 - 32 \right\rbrack^{\circ}$C) for the Chiang Mai province of Thailand ([@bib70]), is depicted in [Fig. 5](#fig5){ref-type="fig"}. This figure shows, that the profile of ${\mathbb{R}}_{0V}$ lies in the range $\left\lbrack 0.18,1.6 \right\rbrack$. Furthermore, the values of ${\mathbb{R}}_{0V}$ increase with increasing temperature values in the range $\left\lbrack 18 - 28 \right\rbrack^{\circ}$C (and decrease thereafter, for increasing temperatures above the peak temperature of $28^{\circ}$C). Thus, disease burden increases with increasing temperature values in the range $\left\lbrack 18 - 28 \right\rbrack^{\circ}$C, and decreases for increasing temperature values thereafter.

### 3.1.3. Effects of vertical transmission on the reproduction number {#sec3.1.3}

The effect of vertical transmission in the vector population (i.e., $r \neq 0$) on the reproduction number (${\mathbb{R}}_{0V}$) is assessed by using the approach in ([@bib67]) as follows. Let $K = \mathcal{F}\mathcal{V}^{- 1}$ (recall that the matrices $\mathcal{F}$ and $\mathcal{V}$ are given by Equation [(3.4)](#fd3_4){ref-type="disp-formula"}) be the next-generation matrix of the autonomous version of the model [(2.1)](#fd2_1){ref-type="disp-formula"} ([@bib25]), given by:$$K = \begin{bmatrix}
K_{11} & K_{12} & K_{13} & K_{14} & 0 & 0 \\
0 & 0 & 0 & 0 & 0 & 0 \\
0 & 0 & 0 & 0 & 0 & 0 \\
0 & 0 & 0 & 0 & K_{45} & K_{46} \\
K_{51} & K_{52} & K_{53} & K_{54} & 0 & 0 \\
0 & 0 & 0 & 0 & 0 & 0 \\
\end{bmatrix},$$where, $K_{11} = \frac{rf_{V}\sigma_{E}\sigma_{L}\sigma_{P}\phi_{V}}{g_{1}g_{2}g_{3}g_{4}}\left( {1 - \frac{S_{M}^{\dagger}}{K_{V}}} \right)_{+}$, $K_{12} = \frac{rf_{V}\sigma_{L}\sigma_{P}\phi_{V}}{g_{2}g_{3}g_{4}}\left( {1 - \frac{S_{M}^{\dagger}}{K_{V}}} \right)_{+}$, $K_{13} = \frac{rf_{V}\sigma_{P}\phi_{V}}{g_{3}g_{4}}\left( {1 - \frac{S_{M}^{\dagger}}{K_{V}}} \right)_{+}$, $K_{14} = \frac{r\phi_{V}}{g_{4}}\left( {1 - \frac{S_{M}^{\dagger}}{K_{V}}} \right)_{+}$, $K_{45} = \frac{a_{V}\beta_{V}\sigma_{H}S_{M}^{\dagger}}{g_{5}g_{6}N_{H}^{\dagger}}$, $K_{46} = \frac{a_{V}\beta_{V}S_{M}^{\dagger}}{g_{6}N_{H}^{\dagger}}$, $K_{51} = \frac{a_{V}f_{V}\beta_{H}\sigma_{E}\sigma_{L}\sigma_{P}}{g_{1}g_{2}g_{3}g_{4}}$, $K_{52} = \frac{a_{V}f_{V}\beta_{H}\sigma_{L}\sigma_{P}}{g_{2}g_{3}g_{4}}$, $K_{53} = \frac{a_{V}f_{V}\beta_{H}\sigma_{P}}{g_{3}g_{4}}$, $K_{54} = \frac{a_{V}\beta_{H}}{g_{4}}$. The notion of *target reproduction number* (as introduced by Shuai et al. ([@bib25]; [@bib67])) will be used. Using the notation in ([@bib67]), the entries $K_{ij}$ ($i,j = 1,\ldots,6$) of the matrix *K* represent the average number of new cases of infections in humans (vectors) generated by an average infected (immature and mature) vector (humans). In particular, the entry $K_{51}$ is the effect of infected eggs ($j = 1$) on the generation of new infected (exposed) humans (i.e., $i = 5$). Furthermore, following ([@bib67]), let $S = \left\{ \left( i,j \right) = \left( 5,1 \right) \right\}$ be the set of target entries and $S_{1} = \left\{ 5 \right\}$ and $S_{2} = \left\{ 1 \right\}$. Following ([@bib67]), it is convenient to define the following projection matrices associated with the autonomous case of the model [(2.1)](#fd2_1){ref-type="disp-formula"}. Let *I* be the $6 \times 6$ identity matrix, $E_{S_{1}}$, $P_{S_{1}}$ and $P_{S_{2}}$ be $6 \times 6$ matrices with entries $\left( E_{S_{1}} \right)_{kk} = 1$ if $k \in S_{1}$ and $\left( E_{S_{1}} \right)_{ij} = 0$ otherwise, and $P_{S_{1}}$ and $P_{S_{2}}$ are $6 \times 6$ projection matrices (e.g., $\left( P_{S_{1}} \right)_{kk} = 1$ if $k \in S_{1}$ and $\left( P_{S_{1}} \right)_{ij} = 0$ otherwise) ([@bib67]). It follows that the target reproduction number (denoted by $T_{S} = T_{r}^{H}$) with respect to the set *S* is given by ([@bib67]):$$T_{r}^{H} = \rho\left( {E_{S_{1}}P_{S_{1}}KP_{S_{2}}\left( {I - K + P_{S_{1}}KP_{S_{2}}} \right)^{- 1}E_{S_{1}}} \right),$$provided the spectral radius $\rho\left( {K - P_{S_{1}}KP_{S_{2}}} \right) < 1$. Hence,$$T_{r}^{H} = \frac{\sigma_{H}{\mathbb{R}}_{0}}{1 - rr_{0}\left( {1 - \frac{S_{M}^{\dagger}}{K_{V}}} \right)_{+}} = \frac{\sigma_{H}{\mathbb{R}}_{0}}{1 - {\mathbb{R}}_{V}^{v}},$$provided $\rho\left( {K - P_{S_{1}}KP_{S_{2}}} \right) = rr_{0}\left( {1 - \frac{S_{M}^{\dagger}}{K_{V}}} \right)_{+} < 1$. It is worth noting that, the expression $\frac{\sigma_{H}{\mathbb{R}}_{0}}{1 - rr_{0}\left( {1 - \frac{S_{M}^{\dagger}}{K_{V}}} \right)_{+}}$ in Equation [(3.6)](#fd3_6){ref-type="disp-formula"} accounts for the average number of infected humans caused by an infected egg (after maturation to adulthood). [Fig. 6](#fig6){ref-type="fig"} compares the target reproduction number ($T_{r}^{H}$) with the basic reproduction number (${\mathbb{R}}_{0V}$) of the autonomous version of the model [(2.1)](#fd2_1){ref-type="disp-formula"} for various values of *r*, from which it follows that $T_{r}^{H}$ is always less than ${\mathbb{R}}_{0V}$ for $r \in \left\lbrack 0,1 \right)$. Furthermore, for the range of the vertical transmission rate for *Aedes aegypti* mosquitoes given in [Table 1](#tbl1){ref-type="table"} (where $r \in \left( {0.0025,0.13} \right)$), it follows from [Fig. 6](#fig6){ref-type="fig"} that vertical transmission has very marginal population-level impact on the disease dynamics (vertical transmission becomes relevant far larger values of *r*, outside the aforementioned realistic range). This result is consistent with the numerical simulation results reported in ([@bib3]).Fig. 6Plot of ${\mathbb{R}}_{0V}$ and $T_{r}^{H}$ as function of *r*. Parameters values used are as given by the baseline values in [Table 3](#tbl3){ref-type="table"}.Fig. 6

[Fig. 7](#fig7){ref-type="fig"} shows that, in the absence of human-mosquito interaction (i.e., no mosquito bites on humans), vertical transmission (*r*) has very marginal effect on the abundance of infected adult female mosquitoes ([Figure (7 a)](#fig7){ref-type="fig"}). However, when the human-mosquito interaction is slightly increased (such as by setting the biting rate to $a_{V} = 0.1$), the number of infected adult female mosquitoes significantly increases with increasing values of the proportion of new infected eggs ([Figure (7 b)](#fig7){ref-type="fig"}). [Figure (7 b)](#fig7){ref-type="fig"} clearly shows that vertical transmission in the vector population has little or no effect on the number of infected adult female mosquitoes (this result supports the finding in [Fig. 6](#fig6){ref-type="fig"}).Fig. 7Simulations of the model [(2.1)](#fd2_1){ref-type="disp-formula"} showing the effect of the proportion of infected eggs (*r*) on the disease dynamics for (a) mosquito-human interaction set at $a_{V} = 0$, (b) mosquito-human interaction set at $a_{V} = 0.1$. Parameter values used are as given in [Table 3](#tbl3){ref-type="table"}.Fig. 7

3.2. Endemic equilibria {#sec3.2}
-----------------------

In this section, conditions for the existence of endemic equilibria will be derived. Let $\mathcal{E}_{1} = \left( {S_{E}^{\text{**}},I_{E}^{\text{**}},S_{L}^{\text{**}},I_{L}^{\text{**}},S_{P}^{\text{**}},I_{P}^{\text{**}},S_{M}^{\text{**}},I_{M}^{\text{**}},S_{H}^{\text{**}},E_{H}^{\text{**}},I_{H}^{\text{**}},R_{H}^{\text{**}}} \right)$ be any arbitrary endemic equilibrium of autonomous version of the model [(2.1)](#fd2_1){ref-type="disp-formula"}. Furthermore, let$$\lambda_{VH}^{\text{**}} = \frac{a_{V}\beta_{H}I_{M}^{\text{**}}}{N_{H}^{\text{**}}},\quad\text{and}\quad N_{H}^{\text{**}} = S_{H}^{\text{**}} + E_{H}^{\text{**}} + I_{H}^{\text{**}} + R_{H}^{\text{**}}.$$

It is convenient to define$${\mathbb{R}}_{0V}^{\text{*}} = {\mathbb{R}}_{0} + {\mathbb{R}}_{V}^{v},$$where, ${\mathbb{R}}_{0}$ and ${\mathbb{R}}_{V}^{v}$ are as defined in Section [3.1.2](#sec3.1.2){ref-type="sec"}. It can be shown that ${\mathbb{R}}_{0V}^{\text{*}} < 1$ ($> 1$) if and only if ${\mathbb{R}}_{0V} < 1$ ($> 1$) (so that ${\mathbb{R}}_{0V}^{\text{*}}$ behaves like the *target reproduction number* discussed in ([@bib68])). It can be shown, by solving for the variables of the autonomous version of the model [(2.1)](#fd2_1){ref-type="disp-formula"} at steady-state, that the solutions of the autonomous model satisfy the following linear equation in terms of $\lambda_{VH}^{\text{**}}$:$$b_{1}\lambda_{VH}^{\text{**}} + b_{0} = 0,$$where, $b_{1} = \mu_{H}\left( {\left( {1 - r} \right)\mu_{V}g_{5}g_{6} + a_{V}\beta_{V}\mu_{H}\sigma_{H}} \right) > 0$, $b_{0} = g_{5}g_{6}\left( {1 - {\mathbb{R}}_{0V}^{\text{*}}} \right)$. It follows from [(3.9)](#fd3_9){ref-type="disp-formula"} that $\lambda_{VH}^{\text{**}} = \frac{- b_{0}}{b_{1}}$, (so that $\lambda_{VH}^{\text{**}} > 0$ ($< 0$) if ${\mathbb{R}}_{01}^{\text{*}} > 1$ ($< 1$)). The components of the positive equilibrium of autonomous version of the model [(2.1)](#fd2_1){ref-type="disp-formula"} can then be obtained by solving for $\lambda_{VH}^{\text{**}}$ from [(3.9)](#fd3_9){ref-type="disp-formula"}, and substituting the result into the steady-state expressions for each of the state variables in [(2.1)](#fd2_1){ref-type="disp-formula"}. It follows that the autonomous case of the model [(2.1)](#fd2_1){ref-type="disp-formula"} has a unique endemic equilibrium whenever ${\mathbb{R}}_{0V}^{\text{*}} > 1$. Thus, the autonomous version of the model [(2.1)](#fd2_1){ref-type="disp-formula"} will not have an endemic equilibrium point if ${\mathbb{R}}_{0V}^{\text{*}} < 1$. Hence, the model will not undergo the usual phenomenon of backward bifurcation ([@bib4]; [@bib18]; [@bib31]; [@bib45]). A global asymptotic stability result is given below for the NDFE ($\mathcal{T}_{1}$). It is convenient, first of all, to define the threshold quantity:$${\mathbb{R}}_{G} = \frac{1}{2}\left\lbrack rr_{0} + \sqrt{rr_{0}^{2} + 4{\mathbb{R}}_{0}} \right\rbrack,$$where, $r_{0}$ and $\text{R}_{0}$ are as defined in Sections [3.1](#sec3.1){ref-type="sec"} and [3.1.2](#sec3.1.2){ref-type="sec"}, respectively. We claim the following result.Theorem 3.3*The NDFE (*$\mathcal{T}_{1}$*) of the autonomous version of the model* [(2.1)](#fd2_1){ref-type="disp-formula"} *is GAS in* $\mathcal{D}$ *whenever* $r_{0} > 1$ *and* ${\mathbb{R}}_{G} < 1$.

The Proof of [Theorem 3.3](#enun_Theorem_3_3){ref-type="statement"}, based on using the approach in ([@bib39], [@bib40]), is given in [Appendix B](#appsec2){ref-type="sec"}. The epidemiological significance of [Theorem 3.3](#enun_Theorem_3_3){ref-type="statement"} is that, for the autonomous version of the model [(2.1)](#fd2_1){ref-type="disp-formula"}, reducing (and maintaining) the threshold quantity (${\mathbb{R}}_{G}$) to a value less than unity is necessary and sufficient for the effective control or elimination of the disease in the community.

3.3. Simulations: effect of temperature variability {#sec3.3}
---------------------------------------------------

The effect of temperature variability on the disease dynamics, as a function of vertical transmission in the vector (*r*), is monitored by simulating the model [(2.1)](#fd2_1){ref-type="disp-formula"} with various fixed temperature values in the range $16^{\circ}$C to $32^{\circ}$C. In the absence of vertical transmission (i.e., $r = 0$), [Fig. 8](#fig8){ref-type="fig"} (a) shows that the disease burden, as measured in terms of the number of new infected humans, increases with increasing temperature values until $28^{\circ}$C (where the maximum peak is attained). The disease burden then decreases for increasing temperatures thereafter. Similar pattern is observed when $10\text{\%}$ vertical transmission is assumed ([Fig. 8](#fig8){ref-type="fig"} (b)), although an increase in the number of new cases in humans is observed as expected. Furthermore, the number of infected mosquitoes exhibit similar pattern (that is, the number of infected adult female mosquitoes increases with increasing temperature until $28^{\circ}$C, and decreases for increasing temperatures thereafter), although oscillatory dynamics, due to the assumed logistic eggs oviposition rate ($\phi_{V}\left( T \right)$), was observed ([Fig. 8](#fig8){ref-type="fig"} (c) and (d)).Fig. 8Simulations of the model [(2.1)](#fd2_1){ref-type="disp-formula"}, for the effect of temperature and vertical transmission on disease dynamics. (a) Total number of symptomatic humans ($I_{H}$) as a function of time for $r = 0$. (b) Total number of symptomatic humans ($I_{H}$) as a function of time for $r = 0.1$. (c) Total number of infected adult mosquitoes ($I_{M}$) as a function of time for $r = 0$. (d) Total number of infected adult mosquitoes ($I_{M}$) as a function of time for $r = 0.1$. Parameters values used are given in [Table 3](#tbl3){ref-type="table"}. The functional forms for the temperature-dependent parameters ($a_{V}\left( T \right)$, $\beta_{H}\left( T \right)$, $\beta_{V}\left( T \right)$, $\phi_{V}\left( T \right)$ and $\mu_{V}\left( T \right)$), given in Section [2](#sec2){ref-type="sec"}, are used.Fig. 8

The overall effect of temperature on disease dynamics is assessed by simulating the model [(2.1)](#fd2_1){ref-type="disp-formula"} using various values of temperature in the range $\left\lbrack 16 - 32 \right\rbrack^{\circ}$C (for Chiang Mai province of Thailand ([@bib70])). The results obtained (depicted in [Fig. 9](#fig9){ref-type="fig"}) show that the total number of new dengue cases (in both the human and mosquito populations) reaches a peak during the period June to August (which correspond to the temperature range of $26^{\circ}$C-- $28^{\circ}$C).Fig. 9Simulation of the model 2.1 for the disease dynamics in Chiang Mai, Thailand. (a) Monthly total number of infected mosquitoes. (b) Monthly total number of infected humans. Parameters values used are given in [Table 3](#tbl3){ref-type="table"}. The functional forms for the temperature-dependent parameters ($a_{V}\left( T \right)$, $\beta_{H}\left( T \right)$, $\beta_{V}\left( T \right)$, $\phi_{V}\left( T \right)$ and $\mu_{V}\left( T \right)$), given in Section [2](#sec2){ref-type="sec"}, are used, using mean monthly temperature (*T*) given in [Table 5](#tbl5){ref-type="table"}.Fig. 9

The potential impact of temperature variability on the burden of disease caused by vertical transmission (*r*) is monitored by simulating the non-autonomous model [(2.1)](#fd2_1){ref-type="disp-formula"} using various value of *r* and temperature. [Fig. 10](#fig10){ref-type="fig"} shows that the effect of *r* in generating new infected cases is more pronounced for temperature values in the range $\left\lbrack 16 - 26 \right\rbrack^{\circ}$C ([Fig. 10](#fig10){ref-type="fig"} (a) and (b)) and decreases thereafter ([Fig. 10](#fig10){ref-type="fig"} (d) and (e)). Thus, this study shows that the ability of vertical transmission to cause significant increase in disease burden is temperature-dependent.Fig. 10Cumulative number of infected humans for various values of the proportion of infected eggs laid by an infected mosquito ($0 \leq r < 1$) and temperature (*T*): (a) $T = 16$, (b) $T = 20$, (c) $T = 28$, (d) $T = 30$, (e) $T = 32$. Color notation from blue ($r = 0$) to gold ($r = 0.9$) represent varying values of *r*, from 0 to 0.9, in steps of length 0.1.Fig. 10

3.4. Uncertainty and sensitivity analysis {#sec3.4}
-----------------------------------------

The autonomous version of the model [(2.1)](#fd2_1){ref-type="disp-formula"}, with fixed temperature values, contains 19 parameters, and uncertainty in their estimates are expected to arise. The effect of such uncertainties is assessed using uncertainty and sensitivity analysis ([@bib15]). In particular, Latin Hypercube Sampling (LHS) and Partial Rank Correlation Coefficients (PRCC) is used for this model, as below. The purpose of sensitivity analysis is to assess the effects of parameters on the outcomes of the simulations of the model ([@bib15]). A highly-sensitive parameter should be more carefully estimated, since a small change in that parameter can cause a large quantitative change in the result ([@bib15]). On the other hand, a parameter that is not sensitive does not require as much attempt to estimate (because a small change in that parameter will not cause a large variation to the quantity of interest) ([@bib12]; [@bib15]; [@bib48]). The analyses will be carried out using data (temperature, demographic and epidemiological) relevant to dengue transmission dynamics in the Chiang Mai province of Thailand ([@bib19]; [@bib44]; [@bib65]; [@bib79]). The total population of the Chiang Mai province is estimated to be 1.7 million, and the average lifespan is 65--72 years ([@bib19]) (so that $\mu_{H} \in \left\lbrack 0.000037 - 0.000042 \right\rbrack$ *per* day with a mean of $\mu_{H}^{\text{*}} = 0.000039$). Thus, $\frac{\text{Π}_{H}}{\mu_{H}^{\text{*}}} = 1.7$ million. Hence, $\text{Π}_{H} \approx 66$ *per* day. The analysis will be carried out using the baseline values and ranges tabulated in [Table 3](#tbl3){ref-type="table"}.

Using the population of infectious humans ($I_{H}$) as the response function, it is shown in [Table 8](#tbl8){ref-type="table"} that the top PRCC-ranked parameters of the model (i.e., parameters with PRCC values greater or equal to 0.5) are the mosquito biting rate ($a_{V}$) and the transmission probability *per* contact for susceptible human ($\beta_{H}$). Similarly, using the population of infectious mosquitoes ($I_{M}$) as the response function, the top PRCC-ranked parameters are the egg deposition rate ($\phi_{V}$), maturation rate of pupae to adult mosquito $\left( \sigma_{P} \right.$) and the environmental carrying capacity of immature mosquitoes $\left( K_{V} \right.$). Furthermore, using the population of infected pupae ($I_{P}$) as the response function, the top PRCC-ranked parameters of the model are the egg deposition rate ($\phi_{V}$), the environmental carrying capacity ($K_{V}$) and the maturation rate of larvae to pupae ($\sigma_{L}$). Considering the population of infected larvae ($I_{L}$) as the response function, the top PRCC-ranked parameters of the model are egg deposition rate ($\phi_{V}$) and maturation rate of eggs to larvae ($\sigma_{E}$). Finally, using the population of infected eggs ($I_{E}$) as the response function, the top PRCC-ranked parameters of the model are egg deposition rate ($\phi_{V}$), the environmental carrying capacity ($K_{V}$) and the natural death rate of adult female mosquitoes ($\mu_{V}$).Table 8PRCC values for the parameters of autonomous case of the model [(2.1)](#fd2_1){ref-type="disp-formula"} using the total number of infected eggs ($I_{E}$), larvae ($I_{L}$), pupae ($I_{P}$), adult mosquitoes ($I_{M}$) and infectious humans ($I_{H}$) as response functions (with PRCC $\geq 0.5$). The top parameters that affect the model with respect to each of the six response functions are highlighted in bold font.Table 8Parameters$I_{E}$$I_{L}$$I_{P}$$I_{M}$$I_{H}$$\sigma_{E}$−0.21966**+0.8402+0.55150.6804**−0.1074$\mu_{E}$−0.0241+0.1490−0.1112+0.0171−0.0313$\sigma_{L}$−0.0334−0.2195**+0.5821**+0.4081+0.0458$\mu_{L}$+0.2574−0.3229−0.0120−0.0845−0.0513$\sigma_{P}$+0.3572+0.0673−0.2042**+0.7500**−0.0245$\mu_{P}$+0.2973+1453−0.3415+0.0376+0.0100$a_{V}$−0.1988+0.3124−0.1143+0.281~**+0.9463**~$\mu_{V}$−0.4202−0.02920.0854+0.1701−0.1462$\mu_{H}$−0.3149−0.3936+0.2996+0.26870.0856$\sigma_{H}$+0.0409−0.1667+0.0184+0.2364−0.0995$\gamma_{H}$+0.0475+0.0176−0.0262+0.1769−0.4349$\text{Π}_{H}$0.0506+0.1099+0.2162−0.0028−0.2039$\beta_{V}$−0.1364−0.1257+0.0843+0.4012+0.1832$\beta_{H}$−0.1176−0.2754−0.2405−0.0476~**+0.8009**~*r*−0.2010+0.1766−0.3528+0.0543−0.0186$f_{V}$+0.2057+0.1517+0.1094+0.3173−0.0903$K_{V}$~**+0.5157**~+0.4100~**+0.6001****+0.7446**~+0.0310$\phi_{V}$~**+0.8603****+0.8999****+0.7805****+0.8113**~−0.0185

In summary, this study identifies four parameters that dominate the transmission dynamics of the autonomous version of the model [(2.1)](#fd2_1){ref-type="disp-formula"}, namely the environmental carrying capacity of immature mosquitoes ($K_{V}$), biting rate ($a_{V}$), probability of infection of a susceptible human ($\beta_{H}$) and the egg oviposition rate ($\phi_{V}$). It is worth noting from [Table 8](#tbl8){ref-type="table"} that the parameter related to vertical transmission in the vector (*r*) does not have significant PRCC values, suggesting that vertical transmission plays a marginal $\cdots$if at all$\cdots$ role on the transmission dynamics of the disease.

4. Analysis of non-autonomous model {#sec4}
===================================

Consider, now, the full non-autonomous model [(2.1)](#fd2_1){ref-type="disp-formula"}, where the function [(2.8)](#fd2_8){ref-type="disp-formula"}, for the daily temperature fluctuations is used (so that the temperature-dependent parameters, given in Equations [(2.5)](#fd2_5){ref-type="disp-formula"}, [(2.6)](#fd2_6){ref-type="disp-formula"}, [(2.7)](#fd2_7){ref-type="disp-formula"}, [(2.3)](#fd2_3){ref-type="disp-formula"}, [(2.4)](#fd2_4){ref-type="disp-formula"}, are now functions of *t*). Although the concept of basic reproduction number has been extensively addressed for autonomous models for disease transmission over the decades, such a concept has only been recently extended to disease transmission models with periodic coefficients (see, for instance ([@bib8]; [@bib9]; [@bib10]; [@bib77]),). In this section, the methodology in ([@bib77]) will be used to compute the reproduction number associated with the non-autonomous model [(2.1)](#fd2_1){ref-type="disp-formula"} with [(2.8)](#fd2_8){ref-type="disp-formula"}. Although the non-autonomous model [(2.1)](#fd2_1){ref-type="disp-formula"} has two disease-free solutions, namely the trivial disease-free equilibrium and a non-trivial disease-free periodic solution, only the non-trivial disease-free periodic solution will be analysed (since the former, associated with the absence of mosquitoes in the population, is ecologically unrealistic). It is convenient to define the functional threshold quantity$$r_{0}\left( t \right) = \frac{\phi_{V}\left( t \right)f_{V}\sigma_{E}\left( t \right)\sigma_{L}\left( t \right)\sigma_{P}\left( t \right)}{\mu_{V}\left( t \right)\left\lbrack \sigma_{E}\left( t \right) + \mu_{E}\left( t \right) \right\rbrack\left\lbrack \sigma_{L}\left( t \right) + \mu_{L}\left( t \right) \right\rbrack\left\lbrack \sigma_{P}\left( t \right) + \mu_{P}\left( t \right) \right\rbrack}.$$

The non-trivial disease-free solution (NDFS), obtained by setting $I_{E} = I_{L} = I_{P} = I_{M} = E_{H} = I_{H} = R_{H} = 0$ in [(2.1)](#fd2_1){ref-type="disp-formula"}, has the form $\varepsilon_{0n}\left( t \right) = \left( {S_{nE}^{\text{*}}\left( t \right),0,S_{nL}^{\text{*}}\left( t \right),0,S_{nP}^{\text{*}}\left( t \right),0,S_{nM}^{\text{*}}\left( t \right),0,\frac{\text{Π}_{H}}{\mu_{H}},0,0,0} \right)$ (recalling that $T = T\left( t \right)$) with $\left( {S_{nE}^{\text{*}}\left( t \right),S_{nL}^{\text{*}}\left( t \right),S_{nP}^{\text{*}}\left( t \right),S_{nM}^{\text{*}}\left( t \right),S_{nH}^{\text{*}}\left( t \right)} \right)^{T}$ being the unique periodic solution (for $r_{0}\left( t \right) > 1$ for all $t \geq 0$) satisfying:$$\begin{array}{l}
{\frac{dS_{nE}^{\text{*}}\left( t \right)}{dt} = \phi_{V}\left( t \right)\left\lbrack 1 - \frac{S_{nM}^{\text{*}}\left( t \right)}{K_{V}\left( t \right)} \right\rbrack_{+}S_{nM}^{\text{*}}\left( t \right) - \left\lbrack \sigma_{E}\left( t \right) + \mu_{E}\left( t \right) \right\rbrack S_{nE}^{\text{*}}\left( t \right),} \\
{\frac{dS_{nL}^{\text{*}}\left( t \right)}{dt} = \sigma_{E}\left( t \right)S_{nE}^{\text{*}}\left( t \right) - \left\lbrack \sigma_{L}\left( t \right) + \mu_{L}\left( t \right) + \delta_{L}\left( t \right)S_{nL}^{\text{*}}\left( t \right) \right\rbrack S_{nL}^{\text{*}}\left( t \right),} \\
{\frac{dS_{nP}^{\text{*}}\left( t \right)}{dt} = \sigma_{L}\left( t \right)S_{nL}^{\text{*}}\left( t \right) - \left\lbrack \sigma_{P}\left( t \right) + \mu_{P}\left( t \right) \right\rbrack S_{nP}^{\text{*}}\left( t \right),} \\
{\frac{dS_{nM}^{\text{*}}\left( t \right)}{dt} = f_{V}\sigma_{P}\left( t \right)S_{nP}^{\text{*}}\left( t \right) - \mu_{V}\left( t \right)S_{nM}^{\text{*}}\left( t \right),} \\
{\frac{dS_{nH}^{\text{*}}\left( t \right)}{dt} = \text{Π}_{H} - \mu_{H}S_{nH}^{\text{*}}\left( t \right).} \\
\end{array}$$

The next generation matrix $F\left( t \right)$ (of the new infection terms) and the M -Matrix $V\left( t \right)$ (of the remaining transfer terms), associated with the non-autonomous model [(2.1)](#fd2_1){ref-type="disp-formula"} with [(2.8)](#fd2_8){ref-type="disp-formula"}, are given, respectively, by$$F\left( t \right) = \begin{bmatrix}
0 & 0 & 0 & {\phi_{V}\left( t \right)r\left( {1 - \frac{S_{nM}^{\text{*}}\left( t \right)}{K_{V}\left( t \right)}} \right)_{+}} & 0 & 0 \\
0 & 0 & 0 & 0 & 0 & 0 \\
0 & 0 & 0 & 0 & 0 & 0 \\
0 & 0 & 0 & 0 & 0 & \frac{\beta_{V}\left( t \right)a_{V}\left( t \right)S_{nM}^{\text{*}}\left( t \right)}{N_{H}^{\text{*}}} \\
0 & 0 & 0 & {\beta_{H}\left( t \right)a_{V}\left( t \right)} & 0 & 0 \\
0 & 0 & 0 & 0 & 0 & 0 \\
\end{bmatrix},$$and,$$V\left( t \right) = \begin{bmatrix}
{v_{1}\left( t \right)} & 0 & 0 & 0 & 0 & 0 & \\
{- \sigma_{E}\left( t \right)} & {v_{2}\left( t \right)} & 0 & 0 & 0 & 0 & \\
0 & {- \sigma_{L}\left( t \right)} & {v_{3}\left( t \right)} & 0 & 0 & 0 & \\
0 & 0 & {- f_{V}\sigma_{P}\left( t \right)} & {v_{4}\left( t \right)} & 0 & 0 & \\
0 & 0 & 0 & 0 & v_{5} & 0 & \\
0 & 0 & 0 & 0 & {- \sigma_{H}} & v_{6} & \\
\end{bmatrix},$$where, $v_{1}\left( t \right) = \sigma_{E}\left( t \right) + \mu_{E}\left( t \right)$, $v_{2}\left( t \right) = \sigma_{L}\left( t \right) + \mu_{L}\left( t \right)$, $v_{3}\left( t \right) = \sigma_{P}\left( t \right) + \mu_{P}\left( t \right)$, $v_{4}\left( t \right) = \mu_{V}\left( t \right)$, $v_{5} = \sigma_{H} + \mu_{H}$, and $v_{6} = \gamma_{H} + \mu_{H}$, $N_{H}^{\text{*}} = \frac{\text{Π}_{H}}{\mu_{H}}$. Let $\mathbf{h} = \left( {h_{1},h_{2},h_{3},h_{4}} \right)^{T}$ be the vector field in the right-hand sides of Equation [(4.1)](#fd4_1){ref-type="disp-formula"} and $\mathbf{x}\left( t \right) = \left( {x_{1}\left( t \right),x_{2}\left( t \right),x_{3}\left( t \right),x_{4}\left( t \right)} \right)^{T}$ $= \left( {S_{nE}^{\text{*}}\left( t \right),S_{nL}^{\text{*}}\left( t \right),S_{nP}^{\text{*}}\left( t \right),S_{nM}^{\text{*}}\left( t \right)} \right)^{T}$. Following ([@bib77]), let $\text{Φ}_{M}$ be the monodromy matrix of the linear ω-periodic system$$\frac{dZ}{dt} = M\left( t \right)Z,$$where, $M\left( t \right) = \left( \frac{\partial h_{i}\left( {\mathbf{x}\left( \mathbf{t} \right),t} \right)}{\partial x_{j}} \right)_{1 \leq i,j \leq 4}$. Further, let $Y\left( {t,s} \right)$ $t \geq s$, be the evolution operator of the linear ω-periodic system$$\frac{dy}{dt} = - V\left( t \right)y,$$that is, for each $s \in {\mathbb{R}}$ , the $6 \times 6$ matrix $Y\left( {t,s} \right)$ satisfies$$\frac{dY\left( {t,s} \right)}{dt} = - V\left( t \right)Y\left( {t,s} \right),\forall t \geq s,Y\left( {s,s} \right) = \mathbb{I}_{6},$$where, $\mathbb{I}_{6}$ is the $6 \times 6$ identity matrix. Suppose that $\phi\left( s \right)$ (ω - periodic in *s*) is the initial distribution of infectious individuals. Thus, $F\left( s \right)\phi\left( s \right)$ is the rate at which new infections are produced by infected individuals who were introduced into the population at time *s* ([@bib77]). Since $t \geq s$, it follows that $Y\left( {t,s} \right)F\left( s \right)\phi\left( s \right)$ is the distribution of those infected individuals who were newly-infected at time *s*, and remain infected at time *t*. Hence, the cumulative distribution of new infections at time *t*, produced by all infected individuals ($\phi\left( s \right)$) introduced at a prior time $s = t$, is given by ([@bib77])$$\text{Ψ}\left( t \right) = \int_{- \infty}^{t}Y\left( {t,s} \right)F\left( s \right)\phi\left( s \right)ds = \int_{0}^{\infty}Y\left( {t,t - a} \right)F\left( {t - a} \right)\phi\left( {t - a} \right)da.$$

Let $C_{\omega}$ be the ordered Banach space of all ω-periodic functions from $\mathbb{R}$ to ${\mathbb{R}}^{6}$, which is equipped with maximum norm and positive cone $C_{\omega}^{+} = \left\{ {\phi \in C_{\omega}:\phi\left( t \right) \geq 0,\forall t \in {\mathbb{R}}} \right\}$. Define a linear operator $\left. L:C_{\omega}^{+}\rightarrow C_{\omega}^{+} \right.$ given by ([@bib77])$$L\left( \phi \right)\left( t \right) = \int_{0}^{\infty}Y\left( {t,t - a} \right)F\left( {t - a} \right)\phi\left( {t - a} \right)da,\quad\forall t \in {\mathbb{R}}^{+},\phi \in C_{\omega}^{+}.$$

The basic reproduction ratio for non-autonomous model [(2.1)](#fd2_1){ref-type="disp-formula"} (denote by $\mathcal{R}_{0n}$) is then given by the spectral radius of the linear operator *L*, denoted by $\rho\left( L \right)$ ([@bib77]). That is, $\mathcal{R}_{0n} = \rho\left( L \right)$. It can be verified that the assumptions $A1 - A7$ in ([@bib77]) are valid for the model [(2.1)](#fd2_1){ref-type="disp-formula"} with periodic parameters. Therefore, the result below is established from Theorem 2.2 in ([@bib77]).Theorem 4.1*Let* $r_{0}\left( t \right) \geq 1$ *for all* $t \geq 0$*. The NDFS (*$\varepsilon_{0n}\left( t \right)$*), of the non-autonomous model* [(2.1)](#fd2_1){ref-type="disp-formula"}*, is LAS if* $\mathcal{R}_{0n} < 1$*, and unstable if* $\mathcal{R}_{0n} > 1.$

We claim the following result.Theorem 4.2*Let* $r_{0}\left( t \right) > 1$*. The NDFS (*$\varepsilon_{0n}\left( t \right)$*) of the special case of the non-autonomous model* [(2.1)](#fd2_1){ref-type="disp-formula"} *is GAS in* ${\mathbb{R}}_{+}^{12} \smallsetminus \left\{ {\mathcal{T}_{0},\mathcal{T}_{1}} \right\}$ *if* $\mathcal{R}_{0n} < 1$.

The Proof of [Theorem 4.2](#enun_Theorem_4_2){ref-type="statement"} is given in [Appendix C](#appsec3){ref-type="sec"}. [Theorem 4.2](#enun_Theorem_4_2){ref-type="statement"} shows that the disease can be effectively-controlled or eliminated if the threshold quantity $\mathcal{R}_{0n}$ can be brought to and maintained at, a value less than unity. In other words, the prospects of such effective control in the Chiang Mai province is promising if the control measures implemented in the province can bring, and maintain, $\mathcal{R}_{0n}$ to a value less than unity.

5. Discussion and conclusions {#sec5}
=============================

This study is based on the design and analysis of a new deterministic model for assessing the impact of vertical transmission, in the vector population, and temperature variability on the transmission dynamics and control of dengue disease. Although dengue is primarily transmitted horizontally (*via* the vector-host-vector transmission cycle), vertical transmission has also been observed in the two main dengue-competent *Aedes* mosquitoes (namely *Aedes albopictus* and *Aedes aegypti* ([@bib33]; [@bib63])) and the human host population ([@bib21]). The consequence of the vertical transmission process is that infected vectors continue to emerge (during favorable temperature and habitat conditions) even when there are no infected hosts, since the infected eggs can survive the dry season and re-emerge as infected adult mosquitoes ([@bib3]; [@bib57]). Temperature affects the dynamics of both immature and adult stages of the dengue-competent mosquito lifecycle by generally affecting vector dynamics (e.g., survival, development, etc.) and mosquito-host interactions (e.g., biting) ([@bib5]).

The new model designed, which incorporates the dynamics of the aquatic stages of the mosquito (including logistic eggs oviposition and density-dependent larval mortality), vertical transmission effects in the vector, was rigorously analysed to gain insight into its dynamical features. It was further shown that, for small enough dengue mortality rate, the non-trivial disease-free equilibrium of autonomous version of the model is globally-asymptotically stable if the associated reproduction number of the model is less than unity. The epidemiological implication of this result is that the disease can be effectively-controlled if the control strategies implemented in the community can bring (and maintain) the reproduction number to a value less than unity. In other words, this result shows that bringing (and maintaining) the reproduction number to a value less than unity is necessary and sufficient for the effective control of the disease in the community.

The model is used to assess the population-level impact of vertical transmission. It should be recalled from [Table 1](#tbl1){ref-type="table"} that proportion of dengue-competent vector born infected (*r*) is quite small (with $r \in \left( {0.0025,0.13} \right)$ ). Numerical simulations of the autonomous version of the model ([Fig. 6](#fig6){ref-type="fig"}(a)) show that vertical transmission has very marginal effect on the disease dynamics. However, when temperature effects are incorporated into the model, simulations of the resulting model show that the effect of vertical transmission is more pronounced for temperature values in the range $\left\lbrack 16 - 26 \right\rbrack^{\circ}$C ([Fig. 10](#fig10){ref-type="fig"}). This effect decreases for temperature values greater than $28^{\circ}$C.

The model designed in this study contains numerous parameters, and the effect of the associated uncertainties of the parameters on the numerical simulations of the model was assessed using Latin Hypercube Sampling (LHS) and Partial Rank Correlation Coefficients (PRCC) ([@bib12]; [@bib15]; [@bib48]), based on parameter values and ranges relevant to dengue transmission dynamics in the Chiang Mai province of Thailand ([@bib70]). These analyses reveal some of the parameters of the model that play a dominant role on the disease transmission dynamics, including the mosquito carrying capacity, biting rate and eggs oviposition rate. Hence, effective dengue control is dependent on the design of strategies that reduce the values of these parameters (e.g., using larviciding and adulticiding to reduce the egg oviposition rate and mosquito carrying capacity, using insecticide-treated bednets and insect repellents to minimize the biting rate). Furthermore, simulations of the model show that vertical transmission has very marginal (if at all) impact on the disease transmission dynamics in the community. Finally, it is shown that dengue-associated burden, as measured in terms of the total number of new dengue cases in humans, increases with increasing mean monthly temperature in the recorded range for Chiang Mai ( $\left\lbrack 16 - 28 \right\rbrack^{\circ}C$). Further, such burden is maximized when the mean monthly temperature lie in the range $\left\lbrack 16 - 28 \right\rbrack^{\circ}C$. This range is recorded in Chiang Mai province during 3--4 months of the year (between June and August). Thus, this study suggests that anti-dengue control efforts should be intensified in the Chiang Mai province of Thailand during these months (this result supports the finding in ([@bib1])). Furthermore, dengue-associated burden decreases with decreasing mean monthly temperature below $15^{\circ}$C and above $32^{\circ}$C and this result supports the finding in ([@bib19]; [@bib31]; [@bib35]; [@bib44]; [@bib65]; [@bib79]).

Appendix A. Monthly dengue incidence data in Chiang Mai province of Thailand ([@bib16]) {#appsec1}
=======================================================================================

Table 9Average monthly DENV incidence in Chiang Mai, Thailand, for the period of 2005--2016.Table 9Month200520062007200820092010201120122013201420152016Average (*per* 100,000)January48121874429191381217803.8February124321443072390913282.3March98327344411517527423.5April2118127454451220573525617.5May1649532227151158876512931917310921.4June1683019959131452514217031208940027751.63July1482171609873221850932523146150400107473.33August1031371569712872304963351691184826162472.61September794798561177115349332818168106786845.14October563548383144283223732408388930323.82November35164327013369402151064091121517.44December99101284441131294225363737.38Table 10Full monthly DENV incidence in Chiang Mai, Thailand, for the period of 2005--2016 ([@bib14]).Table 10Month 2005--2016Temp ( $\circ$C)Rain (mm)DENgue cases**2005**122.604225.5012327.224.79429.857.221529.6104.7164629193.5168728.4179.1148827155.2103926.9436.3791026.8192561125.522.8351222.627.99**2006**122.408225.104328188429.2206.718526.4219.595628.6180.4301726.3269.3217826341.4137926.6194.8471025.769.9351123.90161221.809**2007**12101223.303326.503429.55612526.4393.532627.8130.199726.974.6160826.9153.2156926.8179.8981025.764.648112373.5431221.8010**2008**122.216.621224.513.821327.79.427429.857.274527.3158.7227627.9147.1591727.7101.6987827.2170.9971926.9236.45611026.6188.13831124.234.12701221.57.1128**2009**121.3087225.304432716.734429.597.954528.4142151627.6140.2314727.7124322827.9126.8287927.9191.71771027.3223.4144112501331222.47.544**2010**124.121.744224.4030326.9044431.53.945531.346.4158629.6122.7525728.5114.51850827470.62304927.4196.211531026.8169.62831124.70691223.46.141**2011**122.62.629224.40.87325.360.411427.292.612527.2292.787627.7216.8142727.6191.293826.8260.596927.1254.9491026.469.7221124.96.74012230.613**2012**1231119225.1023327.48.35429.375.920528.5216.465628.155.9170727.5106252827.6185.4335927.6179.63321027.380.13731126.938.82151224.21129**2013**123.225138226.931.690327.617.1175431.21.2573529.889.91293628.939.73120727.9272.93146827.3299.41691927.4275.68181026.2123.42401126.485.4106122126.842**2014**121.3012224.309327.75.92429.634.95529.1236.119628.858.289728175.2150827.4231.3184927.6177.51681027.3129.3831125.816401223.5025**2015**122.378.917224.3013327.927.57429.753.825530.476.5173629.915.2400728.2120.2613828.2143826928.2139.410671027.393.28891126.879.29111224.54.9363**2016**121.634.280224.245.328329.4042432.417.761531.185.7109628.1236.1277727.6162.11074827.7132.11624927.6213.18681027.6141.73031126.3105.32151224673

Appendix B. Proof of [Theorem 3.3](#enun_Theorem_3_3){ref-type="statement"} {#appsec2}
===========================================================================

Proof. Let $r_{0} > 1$ and ${\mathbb{R}}_{G} < 1$. The proof is based on using the approach in ([@bib39], [@bib40]). In particular, the following theorem will be used (where a dot represents differentiation with respect to time *t*).Theorem B.1([@bib39], [@bib40]) *Let* $\mathcal{D} \smallsetminus \left\{ 0 \right\} \subset {\mathbb{R}}_{+}^{6} \times {\mathbb{R}}_{+}^{6}$ , $\mathcal{D}$ *the compact subset defined in Section* [2.3](#sec2.3){ref-type="sec"}. *The system* ([2.1](#fd2_1){ref-type="disp-formula"}) *is* $C^{1}$ *class defined on* $\mathcal{D}$*. If*1.D is positively invariant relative to [(2.1)](#fd2_1){ref-type="disp-formula"};2.The autonomous case of the model [(2.1)](#fd2_1){ref-type="disp-formula"} reduced to the disease-free sub-manifold $D \cap \left( {{\mathbb{R}}_{+}^{6} \times \left\{ 0 \right\}} \right):{\overset{˙}{x}}_{S} = A_{1}\left( {x_{S},0} \right)\left( {x_{S} - x_{S}^{\dagger}} \right)$ is GAS at $x_{S}^{\dagger}$;3.For any $x \in D$, the matrix $A_{2}\left( x \right)$ is Metzler irreducible;4.There exists a matrix $\overline{A_{2}}$ , which is an upper bound of the set $M = \left\{ A_{2}\left( x \right) \in \mathcal{M}_{6}\left( {\mathbb{R}} \right) \middle| x \in \mathcal{D} \right\}$ with the property that if $\overline{A_{2}} \in M$, for any $\overline{x} \in \mathcal{D}$, such that $A_{2}\left( \overline{x} \right) = \overline{A_{2}}$ , then $\overline{x} \in {\mathbb{R}}^{6} \times \left\{ 0 \right\}$;5.The stability modulus of $\overline{A_{2}}$ satisfies $\text{Re}\left( {\rho\left( \overline{A_{2}} \right)} \right) \leq 0$.

Then DFE $\left( {x_{S}^{\dagger},0} \right)$ is GAS in $\mathcal{D}$.

Let $x\left( t \right) = \left( {x_{S}\left( t \right),x_{I}\left( t \right)} \right)$, where, $x_{S}\left( t \right) = \left( {S_{E}\left( t \right),S_{L}\left( t \right),S_{P}\left( t \right),S_{M}\left( t \right),S_{H}\left( t \right),R_{H}\left( t \right)} \right)$, $x_{I}\left( t \right) = \left( {I_{E}\left( t \right),I_{L}\left( t \right),I_{P}\left( t \right),I_{M}\left( t \right),E_{H}\left( t \right),I_{H}\left( t \right)} \right)$. Following ([@bib39]), it is convenient to re-write the autonomous case of the model [(2.1)](#fd2_1){ref-type="disp-formula"} as:$$\begin{array}{l}
{{\overset{˙}{x}}_{S} = A_{1}\left( x \right)\left( {x_{S} - x_{S}^{\dagger}} \right) + A_{12}\left( x \right)x_{I},} \\
{{\overset{˙}{x}}_{I} = A_{2}\left( x \right)x_{I},} \\
\end{array}$$where,$$\begin{array}{l}
{A_{1}\left( x \right) = \left\lbrack \begin{array}{llllll}
{- g_{1}} & 0 & 0 & a_{1,4} & 0 & 0 \\
\sigma_{E} & {- g_{2}} & 0 & 0 & 0 & 0 \\
0 & \sigma_{L} & {- g_{3}} & 0 & 0 & 0 \\
0 & 0 & {f_{V}\sigma_{P}} & {- \mu_{V}} & 0 & 0 \\
0 & 0 & 0 & 0 & {- \mu_{H}} & 0 \\
0 & 0 & 0 & 0 & 0 & {- \mu_{H}} \\
\end{array} \right\rbrack,A_{12}\left( x \right) = \left\lbrack \begin{array}{llllll}
0 & 0 & 0 & b_{1,4} & 0 & 0 \\
0 & 0 & 0 & 0 & 0 & 0 \\
0 & 0 & 0 & 0 & 0 & 0 \\
0 & 0 & 0 & 0 & b_{4,5} & 0 \\
0 & 0 & 0 & b_{5,4} & 0 & 0 \\
0 & 0 & 0 & 0 & 0 & \gamma_{H} \\
\end{array} \right\rbrack,} \\
{A_{2}\left( x \right) = \left\lbrack \begin{array}{llllll}
{- g_{E}} & 0 & 0 & c_{1,4} & 0 & 0 \\
\sigma_{E} & {- g_{L}} & 0 & 0 & 0 & 0 \\
0 & \sigma_{L} & {- g_{P}} & 0 & 0 & 0 \\
0 & 0 & {f_{V}\sigma_{P}} & {- \mu_{V}} & 0 & \frac{a_{V}\beta_{H}S_{H}}{N_{H}} \\
0 & 0 & 0 & \frac{a_{V}\beta_{H}S_{H}}{N_{H}} & {- g_{5}} & 0 \\
0 & 0 & 0 & 0 & \sigma_{H} & {- g_{6}} \\
\end{array} \right\rbrack,} \\
\end{array}$$with $a_{1,4} = \phi_{V}\left( {1 - \frac{S_{M} + S_{M}^{\dagger}}{K_{V}}} \right)$, $b_{1,4} = \phi_{V}\left\lbrack \frac{S_{M}\left( {r - 2} \right)}{K_{V}} + \left( {1 - r} \right)\left( {1 - \frac{S_{M}^{\dagger}}{K_{V}}} \right) \right\rbrack$, $b_{4,5} = - \frac{a_{V}\beta_{V}S_{M}}{N_{H}}$, $b_{5,4} = - \frac{a_{V}\beta_{H}S_{H}}{N_{H}}$, $c_{1,4} = r\phi_{V}\left( {1 - \frac{S_{M} + I_{M}}{K}} \right).$ It can be seen that the eigenvalues of $A_{1}\left( x \right)$ are negative. Therefore, ${\overset{˙}{x}}_{S} = A_{1}\left( {x_{S},0} \right)\left( {x_{S} - x_{S}^{\dagger}} \right)$ is GAS at $x_{S}^{\dagger}$. Furthermore, following ([@bib75]; [@bib74]), the matrix $A_{2}\left( x \right)$ can be written as $A_{2}\left( x \right) = \text{Λ} + B\left( x \right)$, where$$\text{Λ} = \begin{bmatrix}
{- g_{1}} & 0 & 0 & 0 & 0 & 0 \\
\sigma_{E} & {- g_{2}} & 0 & 0 & 0 & 0 \\
0 & \sigma_{L} & {- g_{3}} & 0 & 0 & 0 \\
0 & 0 & {f_{V}\sigma_{P}} & {- \mu_{V}} & 0 & 0 \\
0 & 0 & 0 & 0 & {- g_{5}} & 0 \\
0 & 0 & 0 & 0 & \sigma_{H} & {- g_{6}} \\
\end{bmatrix},B\left( x \right) = \begin{bmatrix}
0 & 0 & 0 & d_{1,4} & 0 & 0 \\
0 & 0 & 0 & 0 & 0 & 0 \\
0 & 0 & 0 & 0 & 0 & 0 \\
0 & 0 & 0 & 0 & 0 & \frac{a_{V}\beta_{V}S_{M}}{N_{H}} \\
0 & 0 & 0 & \frac{a_{V}\beta_{H}S_{H}}{N_{H}} & 0 & 0 \\
0 & 0 & 0 & 0 & 0 & 0 \\
\end{bmatrix},$$with $d_{1,4} = \phi_{V}r\left( {1 - \frac{S_{M} + S_{M}^{\dagger}}{K_{V}}} \right)$. Since $\text{Λ}$ is a Metzler matrix and $B\left( x \right)$ is a positive and bounded matrix, it follows ([@bib40]; [@bib75]; [@bib74]) that the matrix $A_{2}\left( x \right)$ has all eigenvalues with negative real part if and only if ([@bib40])$${\mathbb{R}}_{G} = \rho\left( {- B\text{Λ}^{- 1}} \right) = \frac{1}{2}\left\lbrack rr_{0} + \sqrt{rr_{0}^{2} + 4{\mathbb{R}}_{0}} \right\rbrack < 1.$$

Furthermore, it can be seen that if ${\mathbb{R}}_{G} < 1$, then ${\mathbb{R}}_{0V} < 1$ (since ${\mathbb{R}}_{0V} \leq {\mathbb{R}}_{G}$).

Appendix C. Proof of [Theorem 4.2](#enun_Theorem_4_2){ref-type="statement"} {#appsec3}
===========================================================================

Proof. Consider the special case of the non-autonomous model [(2.1)](#fd2_1){ref-type="disp-formula"}. The model [(2.1)](#fd2_1){ref-type="disp-formula"} can be re-written as (for infected compartments)$$\begin{array}{l}
{\frac{dI_{E}\left( t \right)}{dt} \leq r\phi_{V}\left( t \right)\left\lbrack {1 - \frac{S_{nM}^{\text{*}}\left\lbrack t \right\rbrack}{K_{V}\left\lbrack t \right\rbrack}} \right\rbrack_{+}I_{M} - \left\lbrack {\sigma_{E}\left\lbrack t \right\rbrack + \mu_{E}\left\lbrack t \right\rbrack} \right\rbrack I_{E},} \\
{\frac{dI_{L}\left( t \right)}{dt} \leq \sigma_{E}\left( t \right)I_{E} - \left\lbrack {\sigma_{L}\left\lbrack t \right\rbrack + \mu_{L}\left\lbrack t \right\rbrack} \right\rbrack I_{L},} \\
{\frac{dI_{P}\left( t \right)}{dt} = \sigma_{L}\left( t \right)I_{L} - \left\lbrack {\sigma_{P}\left\lbrack t \right\rbrack + \mu_{P}\left\lbrack t \right\rbrack} \right\rbrack I_{P},} \\
{\frac{dI_{M}\left( t \right)}{dt} \leq f_{V}\sigma_{P}\left( t \right)I_{P} + \frac{a_{V}\left( t \right)\beta_{V}\left( t \right)S_{nM}^{\text{*}}\left( t \right)}{S_{nH}^{\text{*}}\left( t \right)}I_{H} - \mu_{V}\left( t \right)I_{M},} \\
{\frac{dE_{H}\left( t \right)}{dt} \leq a_{V}\left( t \right)\beta_{V}\left( t \right)I_{M} - \left( {\sigma_{H} + \mu_{H}} \right)E_{H},} \\
{\frac{dI_{H}\left( t \right)}{dt} \leq \sigma_{H}E_{H} - \left( {\gamma_{H} + \mu_{H}} \right)I_{H},} \\
{\frac{dR_{H}\left( t \right)}{dt} = \gamma_{H}I_{H} - \mu_{H}R_{H}.} \\
\end{array}$$

The equation [(C.1)](#fdC_1){ref-type="disp-formula"}, with equality used in place of the inequality, can be re-written in terms of the matrices $F\left( t \right)$ and $V\left( t \right)$, as follows$$\frac{dW}{dt} = \left\lbrack F\left( t \right) - V\left( t \right) \right\rbrack W.$$

It follows from Lemma 2.1 in ([@bib81]) that there exists a positive ω-periodic function $w\left( t \right) = \left( {\underset{¯}{I_{E}\left( t \right)},\underset{¯}{I_{L}\left( t \right)},\underset{¯}{I_{P}\left( t \right)},\underset{¯}{I_{M}\left( t \right)},\underset{¯}{E_{H}\left( t \right)},\underset{¯}{I_{H}\left( t \right)},\underset{¯}{R_{H}\left( t \right)}} \right)^{T}$ such that$$W\left( t \right) = \text{e}^{\theta t}w\left( t \right),\quad\text{with}\quad\theta = \frac{1}{\omega}\ln\ \rho\left\lbrack \phi_{F - V}\left( \omega \right) \right\rbrack,$$is a solution of the equation given by [(C.2)](#fdC_2){ref-type="disp-formula"}. Furthermore, the assumption $\mathcal{R}_{0n} < 1$ implies that $\rho\left( {\phi_{F - V}\left( \omega \right)} \right) < 1$ (by Theorem 2.2 in ([@bib77])). Hence, θ is a negative constant. Thus, $\left. W\left( t \right)\rightarrow 0 \right.$ as $\left. t\rightarrow\infty \right.$. Therefore, the unique disease-free solution of the linear system [(C.2)](#fdC_2){ref-type="disp-formula"} given by $W\left( t \right) = 0$ is GAS.

For any non-negative initial solution $w\left( 0 \right) = \left( {\underset{¯}{I_{E}\left( 0 \right)},\underset{¯}{I_{L}\left( 0 \right)},\underset{¯}{I_{P}\left( 0 \right)},\underset{¯}{I_{M}\left( 0 \right)},\underset{¯}{E_{H}\left( 0 \right)},\underset{¯}{I_{H}\left( 0 \right)},\underset{¯}{R_{H}\left( 0 \right)}} \right)^{T}$ of the system [(C.2)](#fdC_2){ref-type="disp-formula"}, there exists a sufficiently large $M^{\text{*}} > 0$ such that$$\left( {I_{E}\left( 0 \right),I_{L}\left( 0 \right),I_{P}\left( 0 \right),I_{M}\left( 0 \right),E_{H}\left( 0 \right),I_{H}\left( 0 \right),R_{H}\left( 0 \right)} \right) < M^{\text{*}}w\left( 0 \right).$$

Thus, by comparison theorem ([@bib69]), it follows that$$\left( {I_{E}\left( t \right),I_{L}\left( t \right),I_{P}\left( t \right),I_{M}\left( t \right),E_{H}\left( t \right),I_{H}\left( t \right),R_{H}\left( t \right)} \right) < M^{\text{*}}W\left( t \right),\quad\text{for}\ \text{all}\quad t \geq 0,$$where, $M^{\text{*}}W\left( t \right)$ is also a solution of [(C.2)](#fdC_2){ref-type="disp-formula"}. Hence, $\left. \left( {I_{E}\left( t \right),I_{L}\left( t \right),I_{P}\left( t \right),I_{M}\left( t \right),E_{H}\left( t \right),I_{H}\left( t \right),R_{H}\left( t \right)} \right)\rightarrow\left( 0,0,0,0,0,0,0 \right) \right.$ as $\left. t\rightarrow\infty \right.$. Finally, it follows from Theorem 1.2 in ([@bib71]) that $\left. \left( {S_{E}\left( t \right),S_{L}\left( t \right),S_{P}\left( t \right),S_{M}\left( t \right),S_{H}\left( t \right)} \right)\rightarrow\left( {S_{nE}^{\text{*}}\left( t \right),S_{nL}^{\text{*}}\left( t \right),S_{nP}^{\text{*}}\left( t \right),S_{nM}^{\text{*}}\left( t \right),S_{nH}^{\text{*}}\left( t \right)} \right) \right.$, where, $\left( {S_{nE}^{\text{*}}\left( t \right),S_{nL}^{\text{*}}\left( t \right),S_{nP}^{\text{*}}\left( t \right),S_{nM}^{\text{*}}\left( t \right),S_{nH}^{\text{*}}\left( t \right)} \right)$ satisfies (4.1). Thus, for $\mathcal{R}_{0n} < 1$,$$\left. \left( {S_{E}\left( t \right),I_{E}\left( t \right),S_{L}\left( t \right),I_{L}\left( t \right),S_{P}\left( t \right),I_{P}\left( t \right),S_{M}\left( t \right),I_{M}\left( t \right),S_{H}\left( t \right),E_{H}\left( t \right),I_{H}\left( t \right),R_{H}\left( t \right)} \right)\rightarrow\varepsilon_{0n}\left( t \right)\ \text{as}\ t\rightarrow\infty. \right.$$

Appendix D. Supplementary data {#appsec4}
==============================

The following is the Supplementary data to this article:Multimedia component 1Multimedia component 1

The authors would like to thank S. Polwiang (Silpakorn University, Bangkok, Thailand) for sharing the incidence data for Chiang Mai province ([Appendix A](#appsec1){ref-type="sec"}). The authors are grateful to the anonymous reviewers for their constructive comments. One of the authors (AG) acknowledges the support, in part, of the Simons Foundation, United States (Grant \#585022).

Peer review under responsibility of KeAi Communications Co., Ltd.

Supplementary data to this article can be found online at <https://doi.org/10.1016/j.idm.2018.09.003>.
